Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	four-way junction helicase activity	BLM RECQL4 RECQL	2.68e-05	6	223	3	GO:0009378
GeneOntologyMolecularFunction	carboxylic ester hydrolase activity	CES1 ACOT9 AARS2 PLA2G4F PON3 ACOT12 LIPE PLA2G4B CES3	6.97e-05	157	223	9	GO:0052689
GeneOntologyMolecularFunction	sodium ion transmembrane transporter activity	TRPM2 NALCN GRIK2 GRIK4 SLC1A7 SLC6A9 SLC9A3 SLC18A1 SLC22A3	1.34e-04	171	223	9	GO:0015081
GeneOntologyMolecularFunction	opsonin binding	ITGAM ITGAV C4A C4B	1.59e-04	25	223	4	GO:0001846
GeneOntologyMolecularFunction	amino acid transmembrane transporter activity	SLC36A1 SLC25A26 GRIK2 GRIK4 SLC1A5 SLC1A7 SLC6A9	1.78e-04	105	223	7	GO:0015171
GeneOntologyMolecularFunction	DNA/DNA annealing activity	BLM RECQL4 RECQL	2.12e-04	11	223	3	GO:1990814
GeneOntologyMolecularFunction	metal ion transmembrane transporter activity	KCNH7 ATP7A TRPM2 ITGAV RYR1 NALCN KCNH2 CACNA2D1 GRIK2 GRIK4 SLC1A7 SLC6A9 SLC9A3 SLC18A1 SLC22A3	2.45e-04	465	223	15	GO:0046873
GeneOntologyMolecularFunction	symporter activity	SLC36A1 MFSD4B SLC1A5 SLC1A7 SLC6A9 SLC18A1 SLC22A3 SLC16A7	2.89e-04	150	223	8	GO:0015293
GeneOntologyMolecularFunction	G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential	ADRB1 GABBR1	3.70e-04	3	223	2	GO:0099579
GeneOntologyMolecularFunction	histone H3K9 acetyltransferase activity	KAT2A KAT2B	3.70e-04	3	223	2	GO:0043992
GeneOntologyMolecularFunction	ligand-gated channel activity	KCNH7 TRPM2 TMEM63B RYR1 KCNH2 GRIK2 GRIK4 SLC1A5 SLC1A7	3.84e-04	197	223	9	GO:0022834
GeneOntologyMolecularFunction	annealing activity	BLM RECQL4 RECQL	4.57e-04	14	223	3	GO:0140666
GeneOntologyMolecularFunction	pyrophosphatase activity	ATP7A TRPM2 BMS1 CLPX BLM CILP2 RECQL4 AFG3L2 GNAS DNM1 HSPA9 VCP DDX17 RECQL BTAF1 RFC1 OPA1 RAB34 ABCE1 HELZ2 DNM3	4.90e-04	839	223	21	GO:0016462
GeneOntologyMolecularFunction	hydrolase activity, acting on acid anhydrides	ATP7A TRPM2 BMS1 CLPX BLM CILP2 RECQL4 AFG3L2 GNAS DNM1 HSPA9 VCP DDX17 RECQL BTAF1 RFC1 OPA1 RAB34 ABCE1 HELZ2 DNM3	4.97e-04	840	223	21	GO:0016817
GeneOntologyMolecularFunction	hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides	ATP7A TRPM2 BMS1 CLPX BLM CILP2 RECQL4 AFG3L2 GNAS DNM1 HSPA9 VCP DDX17 RECQL BTAF1 RFC1 OPA1 RAB34 ABCE1 HELZ2 DNM3	4.97e-04	840	223	21	GO:0016818
GeneOntologyMolecularFunction	secondary active transmembrane transporter activity	SLC36A1 SLC25A26 MFSD4B SLC37A2 SLC1A5 SLC1A7 SLC6A9 SLC9A3 SLC18A1 SLC22A3 SLC16A7	5.20e-04	296	223	11	GO:0015291
GeneOntologyMolecularFunction	3'-5' DNA helicase activity	BLM RECQL4 RECQL	6.91e-04	16	223	3	GO:0043138
GeneOntologyMolecularFunction	inorganic cation transmembrane transporter activity	SLC36A1 KCNH7 ATP7A TRPM2 TMEM63B ITGAV RYR1 NALCN KCNH2 CACNA2D1 GRIK2 GRIK4 SLC1A7 SLC6A9 SLC9A3 SLC18A1 SLC22A3	7.10e-04	627	223	17	GO:0022890
GeneOntologyMolecularFunction	telomeric D-loop binding	BLM RECQL4	7.34e-04	4	223	2	GO:0061821
GeneOntologyMolecularFunction	acetyl-CoA hydrolase activity	ACOT9 ACOT12	7.34e-04	4	223	2	GO:0003986
GeneOntologyMolecularFunction	ligand-gated monoatomic cation channel activity	KCNH7 TRPM2 TMEM63B RYR1 KCNH2 GRIK2 GRIK4	1.01e-03	140	223	7	GO:0099094
GeneOntologyMolecularFunction	neutral L-amino acid transmembrane transporter activity	SLC36A1 SLC1A5 SLC1A7 SLC6A9	1.11e-03	41	223	4	GO:0015175
GeneOntologyMolecularFunction	ribonucleoside triphosphate phosphatase activity	ATP7A BMS1 CLPX BLM RECQL4 AFG3L2 GNAS DNM1 HSPA9 VCP DDX17 RECQL BTAF1 RFC1 OPA1 RAB34 ABCE1 HELZ2 DNM3	1.16e-03	775	223	19	GO:0017111
GeneOntologyMolecularFunction	L-amino acid transmembrane transporter activity	SLC36A1 SLC25A26 SLC1A5 SLC1A7 SLC6A9	1.19e-03	71	223	5	GO:0015179
GeneOntologyMolecularFunction	G protein-coupled receptor activity involved in regulation of postsynaptic membrane potential	ADRB1 GABBR1	1.21e-03	5	223	2	GO:0099530
GeneOntologyMolecularFunction	monoatomic cation transmembrane transporter activity	SLC36A1 KCNH7 ATP7A TRPM2 TMEM63B ITGAV RYR1 NALCN KCNH2 CACNA2D1 GRIK2 GRIK4 SLC1A7 SLC6A9 SLC9A3 SLC18A1 SLC22A3	1.33e-03	664	223	17	GO:0008324
GeneOntologyMolecularFunction	gated channel activity	KCNH7 TRPM2 TMEM63B ITGAV RYR1 KCNH2 CACNA2D1 GRIK2 GRIK4 SLC1A5 SLC1A7	1.39e-03	334	223	11	GO:0022836
GeneOntologyMolecularFunction	ATP hydrolysis activity	ATP7A CLPX BLM RECQL4 AFG3L2 HSPA9 VCP DDX17 RECQL BTAF1 RFC1 ABCE1 HELZ2	1.44e-03	441	223	13	GO:0016887
GeneOntologyMolecularFunction	ligand-gated monoatomic ion channel activity	KCNH7 TRPM2 TMEM63B RYR1 KCNH2 GRIK2 GRIK4 SLC1A7	1.51e-03	193	223	8	GO:0015276
GeneOntologyMolecularFunction	organic anion transmembrane transporter activity	SLC36A1 SLC25A26 SLC37A2 GRIK2 GRIK4 SLC1A5 SLC1A7 SLC6A9 SLC22A3 SLC16A7	1.75e-03	293	223	10	GO:0008514
GeneOntologyMolecularFunction	extracellular matrix protein binding	ITGAV GABBR1	1.81e-03	6	223	2	GO:1990430
GeneOntologyMolecularFunction	kainate selective glutamate receptor activity	GRIK2 GRIK4	1.81e-03	6	223	2	GO:0015277
GeneOntologyMolecularFunction	D-loop DNA binding	BLM RECQL4	1.81e-03	6	223	2	GO:0062037
GeneOntologyMolecularFunction	carboxylesterase activity	CES1 CES3	1.81e-03	6	223	2	GO:0106435
Domain	FG_GAP	ITGA9 ITGAM ITGAV ITFG1 ITGA8	4.43e-06	22	216	5	PS51470
Domain	FG-GAP	ITGA9 ITGAM ITGAV ITFG1 ITGA8	7.02e-06	24	216	5	PF01839
Domain	FG-GAP	ITGA9 ITGAM ITGAV ITFG1 ITGA8	7.02e-06	24	216	5	IPR013517
Domain	DNA_helicase_ATP-dep_RecQ	BLM RECQL4 RECQL	1.50e-05	5	216	3	IPR004589
Domain	Integrin_alpha_C_CS	ITGA9 ITGAM ITGAV ITGA8	2.84e-05	16	216	4	IPR018184
Domain	Integrin_alpha-2	ITGA9 ITGAM ITGAV ITGA8	4.69e-05	18	216	4	IPR013649
Domain	INTEGRIN_ALPHA	ITGA9 ITGAM ITGAV ITGA8	4.69e-05	18	216	4	PS00242
Domain	Integrin_alpha2	ITGA9 ITGAM ITGAV ITGA8	4.69e-05	18	216	4	PF08441
Domain	Integrin_alpha	ITGA9 ITGAM ITGAV ITGA8	4.69e-05	18	216	4	IPR000413
Domain	G_DYNAMIN_1	DNM1 OPA1 DNM3	5.16e-05	7	216	3	PS00410
Domain	DYNc	DNM1 OPA1 DNM3	5.16e-05	7	216	3	SM00053
Domain	Int_alpha	ITGA9 ITGAM ITGAV ITGA8	5.88e-05	19	216	4	SM00191
Domain	Int_alpha_beta-p	ITGA9 ITGAM ITGAV ITGA8	5.88e-05	19	216	4	IPR013519
Domain	Hist_acetylase_PCAF	KAT2A KAT2B	1.33e-04	2	216	2	IPR016376
Domain	Arp1	ACTR1B ACTR1A	1.33e-04	2	216	2	IPR029909
Domain	PCAF_N	KAT2A KAT2B	1.33e-04	2	216	2	IPR009464
Domain	PCAF_N	KAT2A KAT2B	1.33e-04	2	216	2	PF06466
Domain	-	THNSL1 BMS1 CLPX BLM CTPS2 RECQL4 AFG3L2 GNAS DNM1 HS3ST2 VCP DDX17 RECQL BTAF1 RFC1 OPA1 NLRP9 RAB34 ABCE1 HELZ2 DNM3	1.60e-04	746	216	21	3.40.50.300
Domain	A2M	C4A C4B PZP	1.72e-04	10	216	3	PF00207
Domain	A2M_N_2	C4A C4B PZP	1.72e-04	10	216	3	IPR011625
Domain	A2M_comp	C4A C4B PZP	1.72e-04	10	216	3	IPR011626
Domain	Rap_GAP	TSC2 SIPA1 RALGAPA2	1.72e-04	10	216	3	PF02145
Domain	A2M_recep	C4A C4B PZP	1.72e-04	10	216	3	PF07677
Domain	A2M_comp	C4A C4B PZP	1.72e-04	10	216	3	PF07678
Domain	A2M_N	C4A C4B PZP	1.72e-04	10	216	3	PF01835
Domain	A2M_N	C4A C4B PZP	1.72e-04	10	216	3	IPR002890
Domain	A-macroglobulin_rcpt-bd	C4A C4B PZP	1.72e-04	10	216	3	IPR009048
Domain	ALPHA_2_MACROGLOBULIN	C4A C4B PZP	1.72e-04	10	216	3	PS00477
Domain	A2M_N_2	C4A C4B PZP	1.72e-04	10	216	3	PF07703
Domain	Macroglobln_a2	C4A C4B PZP	1.72e-04	10	216	3	IPR001599
Domain	Integrin_dom	ITGA9 ITGAM ITGAV ITGA8	1.82e-04	25	216	4	IPR032695
Domain	Rap_GAP_dom	TSC2 SIPA1 RALGAPA2	2.35e-04	11	216	3	IPR000331
Domain	RAPGAP	TSC2 SIPA1 RALGAPA2	2.35e-04	11	216	3	PS50085
Domain	Integrin_alpha	ITGAM ITGAV ITGA8	2.35e-04	11	216	3	PF00357
Domain	MFS_1	MFSD4B SLC37A2 MFSD9 SLC18A1 SLC22A3 SLC16A7	2.67e-04	77	216	6	PF07690
Domain	MFS	MFSD4B SLC37A2 MFSD9 SLC18A1 SLC22A3 SLC16A7	2.67e-04	77	216	6	IPR011701
Domain	P-loop_NTPase	THNSL1 MYO9A BMS1 CLPX BLM CTPS2 RECQL4 AFG3L2 GNAS DNM1 HS3ST2 VCP DDX17 RECQL BTAF1 RFC1 OPA1 NLRP9 RAB34 ABCE1 HELZ2 DNM3	3.49e-04	848	216	22	IPR027417
Domain	RQC_domain	BLM RECQL	3.96e-04	3	216	2	IPR018982
Domain	K_chnl_volt-dep_ERG	KCNH7 KCNH2	3.96e-04	3	216	2	IPR003967
Domain	RQC	BLM RECQL	3.96e-04	3	216	2	PF09382
Domain	G_DYNAMIN_dom	DNM1 OPA1 DNM3	5.05e-04	14	216	3	IPR030381
Domain	G_DYNAMIN_2	DNM1 OPA1 DNM3	5.05e-04	14	216	3	PS51718
Domain	Dynamin_GTPase	DNM1 OPA1 DNM3	6.26e-04	15	216	3	IPR001401
Domain	Dynamin_SF	DNM1 OPA1 DNM3	6.26e-04	15	216	3	IPR022812
Domain	Dynamin_N	DNM1 OPA1 DNM3	6.26e-04	15	216	3	PF00350
Domain	RecQ_Zn_bind	BLM RECQL	7.87e-04	4	216	2	PF16124
Domain	RecQ_Zn-bd	BLM RECQL	7.87e-04	4	216	2	IPR032284
Domain	HOTDOG_ACOT	ACOT9 ACOT12	7.87e-04	4	216	2	IPR033120
Domain	HOTDOG_ACOT	ACOT9 ACOT12	7.87e-04	4	216	2	PS51770
Domain	MFS_dom	MFSD4B SLC37A2 MFSD9 SLC2A5 SLC18A1 SLC22A3 SLC16A7	9.53e-04	134	216	7	IPR020846
Domain	Terpenoid_cyclase/PrenylTrfase	C4A C4B PZP	1.09e-03	18	216	3	IPR008930
Domain	zf-C2H2_6	ZNF93 ZNF626 ZNF442 ZNF506 ZNF680 ZNF695 OSR2 ZNF253 ZNF737 ZNF85 ZNF90	1.11e-03	314	216	11	PF13912
Domain	Anaphylatoxin_comp_syst	C4A C4B	1.30e-03	5	216	2	IPR018081
Domain	Anaphylatoxn_comp_syst_dom	C4A C4B	1.30e-03	5	216	2	IPR001840
Domain	MFS	SLC37A2 MFSD9 SLC2A5 SLC18A1 SLC22A3 SLC16A7	1.60e-03	108	216	6	PS50850
Domain	Dynamin_central	DNM1 DNM3	1.94e-03	6	216	2	IPR000375
Domain	GED	DNM1 DNM3	1.94e-03	6	216	2	SM00302
Domain	Dynamin_M	DNM1 DNM3	1.94e-03	6	216	2	PF01031
Domain	GED_dom	DNM1 DNM3	1.94e-03	6	216	2	IPR020850
Domain	GED	DNM1 DNM3	1.94e-03	6	216	2	PS51388
Domain	Dynamin_GTPase_CS	DNM1 DNM3	1.94e-03	6	216	2	IPR019762
Domain	GED	DNM1 DNM3	1.94e-03	6	216	2	PF02212
Domain	GED	DNM1 DNM3	1.94e-03	6	216	2	IPR003130
Domain	-	HLA-G MICB CD1E	2.58e-03	24	216	3	3.30.500.10
Domain	MHC_I-like_Ag-recog	HLA-G MICB CD1E	2.58e-03	24	216	3	IPR011161
Domain	ANATO	C4A C4B	2.69e-03	7	216	2	SM00104
Domain	NA_DICARBOXYL_SYMP_1	SLC1A5 SLC1A7	2.69e-03	7	216	2	PS00713
Domain	NA_DICARBOXYL_SYMP_2	SLC1A5 SLC1A7	2.69e-03	7	216	2	PS00714
Domain	PLA2_B	PLA2G4F PLA2G4B	2.69e-03	7	216	2	PF01735
Domain	PLA2C	PLA2G4F PLA2G4B	2.69e-03	7	216	2	PS51210
Domain	ANAPHYLATOXIN_2	C4A C4B	2.69e-03	7	216	2	PS01178
Domain	ANAPHYLATOXIN_1	C4A C4B	2.69e-03	7	216	2	PS01177
Domain	SDF	SLC1A5 SLC1A7	2.69e-03	7	216	2	PF00375
Domain	-	SLC1A5 SLC1A7	2.69e-03	7	216	2	1.10.3860.10
Domain	4HBT	ACOT9 ACOT12	2.69e-03	7	216	2	PF03061
Domain	LysoPLipase_cat_dom	PLA2G4F PLA2G4B	2.69e-03	7	216	2	IPR002642
Domain	ANATO	C4A C4B	2.69e-03	7	216	2	PF01821
Domain	Na-dicarboxylate_symporter	SLC1A5 SLC1A7	2.69e-03	7	216	2	IPR001991
Domain	Na-dicarboxylate_symporter_CS	SLC1A5 SLC1A7	2.69e-03	7	216	2	IPR018107
Domain	Thioestr_dom	ACOT9 ACOT12	2.69e-03	7	216	2	IPR006683
Domain	PLAc	PLA2G4F PLA2G4B	2.69e-03	7	216	2	SM00022
Domain	Anaphylatoxin/fibulin	C4A C4B	2.69e-03	7	216	2	IPR000020
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	PDCD2 MYO9A CORO1C BMS1 HNRNPM CLPX DDOST NPM3 BLM UBR5 AHNAK RECQL4 AFG3L2 TAF2 HSPA9 HSPB8 VCP FLII FLNC DDX17 DSC1 ESYT1 RECQL FASTKD2 RFC1 IPO4 USP16 SLC1A5 RBM39 WDR47 ACTR1B ACTR1A RAB34 ABCE1 ASNS ATIC	4.60e-13	1353	223	36	29467282
Pubmed	ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.	EPHX1 MATN2 SREBF1 TSC2 ITGAV PMEPA1 PTGS1 DDOST GGCX B3GAT3 ITFG1 GPR180 GANAB C4A C1QTNF6 HECTD1 VCP RCE1 CACNA2D1 GALNT10 ESYT1 ARFGEF1 EMC9 LAMB2 RECQL GRIK2 CPT1A RAB34 ABCE1 SLC22A3 NGLY1	4.91e-11	1201	223	31	35696571
Pubmed	Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells.	EPHX1 CORO1C BMS1 HNRNPM SREK1 CLPX ITGAM AARS2 AHNAK IRF2BPL GNAS HSPA9 VCP SIN3B FLNC DDX17 DSC1 ESYT1 ARFGEF1 DPYSL4 RECQL RFC1 IPO4 OPA1 RBM39 ACTR1A CRYZ RAB34 ABCE1 PDP1 ASNS ATIC NGLY1	6.27e-11	1367	223	33	32687490
Pubmed	C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains.	STK26 INTS1 HNRNPM RHBDD2 TSC2 CLPX DDOST GGCX GANAB CTPS2 UBR5 AFG3L2 GNAS HECTD1 HSPA9 VCP FLII DDX17 DSC1 ESYT1 BTAF1 RFC1 CPT1A IPO4 SLC1A5 OPA1 RBM39 ACTR1A ABCE1 ASNS MTR	1.51e-10	1257	223	31	37317656
Pubmed	In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine.	STK26 HNRNPM ALDH1L1 ITGAM ITGAV ITFG1 CILP2 SERPINB8 GANAB C4A C4B GNAS DNM1 PZP VCP AMBP CACNA2D1 DSC1 FOLH1 LAMB2 SLC2A5 ACTR1B ACTR1A CRYZ DNM3 ATIC ENO2 CDH16	3.40e-10	1070	223	28	23533145
Pubmed	Protein interactome mining defines melatonin MT1 receptors as integral component of presynaptic protein complexes of neurons.	MYO9A INTS1 SREBF1 CTPS2 GNAS DNM1 HECTD1 HSPA9 IPO4 RBM39 ACTR1B CRYZ LIPE PRKCH ATIC ENO2	3.69e-10	322	223	16	26514267
Pubmed	A high-throughput approach for measuring temporal changes in the interactome.	PCYT1A CORO1C STK26 HNRNPM NHLRC2 MEA1 NPM3 GANAB CTPS2 AHNAK IRF2BPL DNM1 HECTD1 HSPA9 VCP FLII FLNC GINS3 DDX17 LAMB2 RECQL IPO4 PAAF1 ACTR1B ACTR1A CRYZ ABCE1 ASNS MTR ATIC TATDN1 ENO2	1.26e-09	1455	223	32	22863883
Pubmed	ARHGAP24 represses β-catenin transactivation-induced invasiveness in hepatocellular carcinoma mainly by acting as a GTPase-independent scaffold.	ZNF93 CORO1C HNRNPM CLPX GANAB ZNF506 HSPA9 VCP DDX17 ZNF680 SLC1A5 OPA1 RBM39 ABCE1 ATIC USP39 ENO2	6.71e-09	451	223	17	36168627
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	INTS1 BMS1 CUL9 BLM GANAB UBR5 AHNAK HECTD1 HSPA9 VCP FLNC RECQL RFC1 IPO4 VIRMA RBM39 ABCE1 ASNS HELZ2 ATIC	1.01e-08	653	223	20	22586326
Pubmed	LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling.	STK26 HNRNPM TSC2 DDOST B3GAT3 GPR180 GANAB CTPS2 AARS2 UBR5 HECTD1 VCP ESYT1 ARFGEF1 BTAF1 CPT1A IPO4 SLC1A5 OPA1 TRABD NISCH ASNS MTR ATIC	1.13e-08	942	223	24	31073040
Pubmed	Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis.	ACOT9 CORO1C HNRNPM NHLRC2 ALDH1L1 DDOST RYR1 GANAB AHNAK ELAPOR1 GNAS VCP FLNC DDX17 ESYT1 CPT1A IPO4 SLC1A5 ACTR1A AKAP9 ABCE1 ATIC	1.46e-08	807	223	22	30575818
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	SECISBP2L THNSL1 ACOT9 SREBF1 RHBDD2 CLPX DDOST GORASP1 RECQL4 AFG3L2 C4A C4B DNM1 PZP EPB41L4B BTAF1 ABCE1 NISCH MTR	5.01e-08	650	223	19	38777146
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	INTS1 SREBF1 CUL9 TSC2 KAT2A PTCH1 RYR1 JAK2 KCNH2 AHNAK HECTD1 FLII FLNC ESYT1 LAMB2 BTAF1 RALGAPA2 ADGRA2 SLC1A5 ACTR1A PLA2G4B BTBD7 NISCH HELZ2 TXNRD3	5.55e-08	1105	223	25	35748872
Pubmed	Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors.	EPHX1 ACOT9 MATN2 INTS1 HNRNPM HLA-G RHBDD2 CLPX ITGAV PTGS1 DDOST GGCX XYLT1 GANAB AARS2 AHNAK GNAS HSPA9 VCP FLNC ESYT1 PON3 LAMB2 FASTKD2 RBM39 ECHDC3 RAB34 AKAP9 CPEB4	6.44e-08	1451	223	29	30550785
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	INTS1 BMS1 HNRNPM HLA-G TSC2 PTGS1 OR52N1 DDOST RYR1 JAK2 AHNAK RECQL4 RCE1 GALNTL6 SIN3B EPB41L4B ABCE1 ASNS ATIC USP39	7.19e-08	736	223	20	29676528
Pubmed	The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery.	EPHX1 INTS1 HNRNPM SREBF1 RHBDD2 ITGAV DDOST GGCX ITFG1 BLM GANAB AHNAK AFG3L2 TAF2 GNAS HSPA9 VCP FLNC DSC1 ESYT1 TP53I11 LAMB2 FASTKD2 VIRMA SLC1A5 RAB34	7.26e-08	1203	223	26	29180619
Pubmed	A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling.	BMS1 NHLRC2 DDOST GANAB FBXO3 UBR5 AFG3L2 GNAS HECTD1 VCP FLNC ESYT1 LAMB2 PTPRU CPT1A IPO4 PAAF1 SLC1A5 OPA1 RAB34 ABCE1 ASNS NGLY1	9.17e-08	974	223	23	28675297
Pubmed	PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation.	HNRNPM CILP2 GANAB AHNAK C4A C4B HSPA9 VCP FLNC DDX17 DSC1 SLC1A5 OPA1 RBM39 ASNS ATIC	9.39e-08	477	223	16	31300519
Pubmed	Tumor suppressor BAP1 nuclear import is governed by transportin-1.	PCYT1A CORO1C STK26 HNRNPM NHLRC2 NPM3 GANAB UBR5 AHNAK GNAS HSPA9 VCP FLII FLNC DDX17 RECQL RFC1 IPO4 RBM39 ACTR1A NISCH ASNS ATIC USP39 ENO2	1.16e-07	1149	223	25	35446349
Pubmed	Cell cycle-dependent phosphorylation regulates RECQL4 pathway choice and ubiquitination in DNA double-strand break repair.	PDCD2 CORO1C HNRNPM DDOST NPM3 GANAB CTPS2 FBXO3 UBR5 RECQL4 AFG3L2 GNAS HECTD1 HSPA9 VCP OPLAH FLII GINS3 DDX17 FASTKD2 RFC1 IPO4 SLC1A5 OPA1 ACTR1A BTBD7 ASNS	1.51e-07	1335	223	27	29229926
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	EPHX1 CORO1C BMS1 HNRNPM SREK1 CLPX DDOST NPM3 GANAB GNAS HSPA9 FLII DDX17 DSC1 ESYT1 RECQL FASTKD2 RFC1 IPO4 SLC1A5 OPA1 RBM39 ACTR1A ABCE1 ASNS MTR ATIC USP39	1.57e-07	1425	223	28	30948266
Pubmed	Defining the human deubiquitinating enzyme interaction landscape.	PDCD2 THNSL1 CORO1C BMS1 KAT2A CLPX DDOST ERCC8 CTPS2 FBXO3 UBR5 AFG3L2 HECTD1 VCP FLNC DSC1 BTBD2 IPO4 PAAF1 USP16 SLC1A5 ABCE1 USP39	1.60e-07	1005	223	23	19615732
Pubmed	Proteomic identification of common SCF ubiquitin ligase FBXO6-interacting glycoproteins in three kinds of cells.	ACOT9 HNRNPM CLPX ITGAV PTGS1 DDOST GGCX ITFG1 CILP2 GANAB AFG3L2 HSPA9 DDX17 LAMB2 CPT1A ABCE1 NGLY1	5.39e-07	613	223	17	22268729
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	EPHX1 RELN INTS1 BMS1 HNRNPM SREK1 DDOST BLM GANAB FBXO3 DNM1 PZP VCP FLNC DDX17 DPYSL4 OPA1 RBM39 CPEB4 HELZ2 DNM3 ELAVL3 USP39	5.77e-07	1082	223	23	38697112
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	MYO9A CORO1C STK26 HNRNPM ALDH1L1 AFG3L2 C4A C4B DNM1 HSPA9 VCP FLII CACNA2D1 FLNC DDX17 EPB41L4B DPYSL4 SIPA1 VIRMA OPA1 RBM39 WDR47 ACTR1A NISCH CPEB4 ELAVL3 ENO2	5.86e-07	1431	223	27	37142655
Pubmed	Defining the membrane proteome of NK cells.	ATP7A INTS1 HNRNPM HLA-G DDOST B3GAT3 GANAB UBR5 AHNAK RECQL4 GNAS RCE1 DDX17 ESYT1 RECQL CPT1A IPO4 SLC1A5 OPA1 ACTR1B ABCE1 NISCH HELZ2 ATIC	5.90e-07	1168	223	24	19946888
Pubmed	Quantitative Proteomics Reveals Dynamic Interactions of the Minichromosome Maintenance Complex (MCM) in the Cellular Response to Etoposide Induced DNA Damage.	MYO9A HNRNPM CLPX DDOST NPM3 SERPINB8 GANAB FBXO3 AHNAK C4A C4B HSPA9 VCP FLNC DDX17 DSC1 FASTKD2 SLC1A5 OPA1 ABCE1	6.26e-07	844	223	20	25963833
Pubmed	Regulator of sex-limitation (Rsl) encodes a pair of KRAB zinc-finger genes that control sexually dimorphic liver gene expression.	ZNF93 ZNF626 ZNF506 ZNF695 ZNF85	1.09e-06	29	223	5	14563677
Pubmed	Germline polymorphisms in the one-carbon metabolism pathway and DNA methylation in colorectal cancer.	ALDH1L1 FOLH1 MTR ATIC	1.12e-06	13	223	4	19936946
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	CORO1C HNRNPM TSC2 UBR5 DNM1 HSPA9 FLII SIN3B CACNA2D1 DPYSL4 GRIK2 SIPA1 IPO4 VIRMA OPA1 WDR47 ACTR1A AKAP9 NISCH DNM3 ELAVL3	1.23e-06	963	223	21	28671696
Pubmed	Acetylation of ELF5 suppresses breast cancer progression by promoting its degradation and targeting CCND1.	PDCD2 STK26 HNRNPM CLPX DDOST GANAB HSPA9 VCP FLII DDX17 BTAF1 IPO4 SLC1A5 OPA1 RBM39 ABCE1 ASNS	1.28e-06	653	223	17	33742100
Pubmed	Host E3 ligase HUWE1 attenuates the proapoptotic activity of the MERS-CoV accessory protein ORF3 by promoting its ubiquitin-dependent degradation.	EPHX1 HNRNPM GANAB AARS2 UBR5 AFG3L2 GNAS HECTD1 VCP RECQL RBM39 ACTR1A ABCE1 ASNS USP39	2.18e-06	534	223	15	35032548
Pubmed	Interactome Analysis of Human Phospholipase D and Phosphatidic Acid-Associated Protein Network.	ACOT9 ITGAV B3GAT3 GANAB MICB VCP ESYT1 CPT1A OPA1 RAB34 TRABD	2.38e-06	282	223	11	35007762
Pubmed	A role for Mac-1 (CDIIb/CD18) in immune complex-stimulated neutrophil function in vivo: Mac-1 deficiency abrogates sustained Fcgamma receptor-dependent neutrophil adhesion and complement-dependent proteinuria in acute glomerulonephritis.	ITGAM C4A C4B	2.58e-06	5	223	3	9382884
Pubmed	RecQ helicase expression in patients with telomeropathies.	BLM RECQL4 RECQL	2.58e-06	5	223	3	38874681
Pubmed	Growth factor-dependent phosphorylation of the actin-binding protein cortactin is mediated by the cytoplasmic tyrosine kinase FER.	FER DNM1 DNM3	2.58e-06	5	223	3	9722593
Pubmed	Clustered organization of homologous KRAB zinc-finger genes with enhanced expression in human T lymphoid cells.	ZNF93 ZNF737 ZNF85 ZNF90	2.82e-06	16	223	4	8467795
Pubmed	Large-scale proteomics and phosphoproteomics of urinary exosomes.	PDCD2 FBP2 ALDH1L1 ADGRV1 ITGAV RYR1 BTG2 GANAB AHNAK VCP AMBP CACNA2D1 SLC2A5 ACTR1A VPS13D CRYZ SLC9A3 RAB34 ARSL PRKCH ATIC	2.84e-06	1016	223	21	19056867
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	CORO1C INTS1 DDOST GANAB AARS2 UBR5 AHNAK AFG3L2 GNAS HSPA9 VCP FLII CACNA2D1 FLNC DDX17 LAMB2 BTAF1 SLC1A5 RBM39 ATIC USP39	3.20e-06	1024	223	21	24711643
Pubmed	Rewiring of the Human Mitochondrial Interactome during Neuronal Reprogramming Reveals Regulators of the Respirasome and Neurogenesis.	EPHX1 ACOT9 CORO1C CUL9 ITGAV DDOST GANAB AARS2 HSPA9 VCP CACNA2D1 ESYT1 CPT1A SLC1A5 CRYZ EHHADH PDP1 ATIC ENO2	3.29e-06	859	223	19	31536960
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	HNRNPM CUL9 SREK1 KAT2A CLPX GGCX NPM3 KAT2B UBR5 AFG3L2 TAF2 VCP GINS3 SIPA1 RALGAPA2 OPA1 TRABD CPEB4 NEURL1 MTR CDH16 SP140	3.48e-06	1116	223	22	31753913
Pubmed	Tau interactome maps synaptic and mitochondrial processes associated with neurodegeneration.	ACOT9 CORO1C ALDH1L1 AHNAK AFG3L2 GNAS DNM1 OPLAH FLNC DPYSL4 WDR47 ACTR1B ACTR1A ELAVL3 ENO2	3.72e-06	558	223	15	35063084
Pubmed	A High-Density Human Mitochondrial Proximity Interaction Network.	THNSL1 ACOT9 BMS1 TSC2 CLPX DDOST BLM GANAB AARS2 AFG3L2 GNAS HSPA9 VCP FLII ESYT1 FASTKD2 OPA1 RBM39 VPS13D CRYZ AKAP9 ABCE1 TRABD NISCH MTR PRKCH	4.29e-06	1496	223	26	32877691
Pubmed	USP11 mediates repair of DNA-protein cross-links by deubiquitinating SPRTN metalloprotease.	ACOT9 HNRNPM NHLRC2 CTPS2 AFG3L2 HSPA9 VCP DDX17 RFC1 CPT1A SLC1A5 RBM39 ABCE1 NISCH ASNS	4.32e-06	565	223	15	33567341
Pubmed	STUB1 is targeted by the SUMO-interacting motif of EBNA1 to maintain Epstein-Barr Virus latency.	STK26 GANAB C4A FLNC RECQL BTAF1 SIPA1 RBM39 ACTR1B	4.57e-06	192	223	9	32176739
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	CORO1C ALDH1L1 SREK1 BLM AFG3L2 C4A C4B FLII RECQL OPA1 RBM39 VPS13D USP39 CSPP1	4.64e-06	497	223	14	36774506
Pubmed	CTDP1 regulates breast cancer survival and DNA repair through BRCT-specific interactions with FANCI.	INTS1 TSC2 UBR5 AMBP ARFGEF1 BTAF1 OPA1	5.08e-06	104	223	7	31240132
Pubmed	Sir2 regulates skeletal muscle differentiation as a potential sensor of the redox state.	KAT2A KAT2B SP140	5.13e-06	6	223	3	12887892
Pubmed	Identification of anchor genes during kidney development defines ontological relationships, molecular subcompartments and regulatory pathways.	FBP2 ALDH1L1 ITGA9 MFSD4B VDR AMBP AFF3 RBM39 SLC18A1	5.63e-06	197	223	9	21386911
Pubmed	LukS-PV inhibits hepatocellular carcinoma cells migration by downregulating HDAC6 expression.	ACOT9 CORO1C HNRNPM KAT2A DDOST AHNAK GNAS HSPA9 FLII DDX17 CPT1A RBM39 ACTR1A ARSL ATIC	5.91e-06	580	223	15	35676659
Pubmed	Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.	ACOT9 CORO1C MATN2 STK26 HNRNPM DDOST GANAB AFG3L2 GNAS HECTD1 HSPA9 VCP FLII DDX17 RECQL RFC1 OPA1 RBM39 ACTR1A AKAP9 ABCE1 ASNS ATIC	6.16e-06	1247	223	23	27684187
Pubmed	A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.	BMS1 TSC2 CLPX DDOST NPM3 GANAB AARS2 UBR5 AHNAK MICB AFG3L2 IRF2BPL GNAS VCP CACNA2D1 ESYT1 RECQL BTAF1 RFC1 IPO4 SLC1A5 RBM39 ACTR1A ASNS USP39	6.78e-06	1440	223	25	30833792
Pubmed	Somatic mutations and germline sequence variants in the expressed tyrosine kinase genes of patients with de novo acute myeloid leukemia.	JAK2 FLT3 NTRK1	8.93e-06	7	223	3	18270328
Pubmed	Murine candidate bleomycin induced pulmonary fibrosis susceptibility genes identified by gene expression and sequence analysis of linkage regions.	HLA-G C4A C4B GABBR1	9.04e-06	21	223	4	15937080
Pubmed	HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.	SECISBP2L TRPM2 BMS1 CLPX ITGAV DDOST GGCX NPM3 AHNAK C4B GNAS HSPA9 VCP AMBP FLII ESYT1 RFC1 VIRMA SLC1A5 CRYZ AKAP9 EHHADH CPEB4 HELZ2	9.14e-06	1371	223	24	36244648
Pubmed	SARS-CoV-2 uses Spike glycoprotein to control the host's anaerobic metabolism by inhibiting LDHB.	CORO1C DDOST NPM3 GANAB AARS2 ESYT1 RECQL IPO4 VIRMA ACTR1A CRYZ ABCE1 ASNS ATIC USP39	1.01e-05	607	223	15	39147351
Pubmed	Systematic identification of SH3 domain-mediated human protein-protein interactions by peptide array target screening.	KCNH7 CUL9 RYR1 JAK2 DNM1 FLNC SLC22A3 DNM3 MAP2K5 DKKL1 GABBR1	1.03e-05	329	223	11	17474147
Pubmed	Ubiquilin 2 modulates ALS/FTD-linked FUS-RNA complex dynamics and stress granule formation.	HNRNPM ALDH1L1 DDOST B3GAT3 AFG3L2 GNAS HSPA9 VCP DSC1 ESYT1	1.05e-05	269	223	10	30442662
Pubmed	An important role for CDK2 in G1 to S checkpoint activation and DNA damage response in human embryonic stem cells.	HNRNPM GANAB AHNAK HSPA9 VCP FLNC DDX17 DSC1 ESYT1 ASNS ATIC ENO2	1.12e-05	397	223	12	21319273
Pubmed	Systematically defining selective autophagy receptor-specific cargo using autophagosome content profiling.	PCYT1A BMS1 CLPX ITGAV DDOST GPR180 GANAB FBXO3 UBR5 AHNAK AFG3L2 GNAS HECTD1 HSPA9 VCP CACNA2D1 DDX17 ESYT1 RECQL FASTKD2 RFC1 CPT1A SLC1A5	1.16e-05	1297	223	23	33545068
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	ATP7A BMS1 HNRNPM SREK1 CLPX DDOST BLM GANAB UBR5 AFG3L2 GNAS HSPA9 VCP ESYT1 EMC9 FASTKD2 IPO4 USP16 SLC1A5 AKAP9 TRABD NISCH ASNS MTR CSPP1	1.17e-05	1487	223	25	33957083
Pubmed	Delineating WWOX Protein Interactome by Tandem Affinity Purification-Mass Spectrometry: Identification of Top Interactors and Key Metabolic Pathways Involved.	RHBDD2 DDOST GGCX GANAB AFG3L2 ESYT1 SLC1A5 ABCE1 ASNS	1.22e-05	217	223	9	30619736
Pubmed	The Effects of Maternal Intake of EPA and DHA Enriched Diet During Pregnancy and Lactation on Offspring's Muscle Development and Energy Homeostasis.	SREBF1 ADRB1 CPT1A LIPE EHHADH	1.28e-05	47	223	5	35733999
Pubmed	C3 opsonization regulates endocytic handling of apoptotic cells resulting in enhanced T-cell responses to cargo-derived antigens.	ITGAM C4A C4B	1.42e-05	8	223	3	24474777
Pubmed	A Unique Role of Carboxylesterase 3 (Ces3) in β-Adrenergic Signaling-Stimulated Thermogenesis.	CES1 LIPE CES3	1.42e-05	8	223	3	30862682
Pubmed	The evolutionarily conserved Krüppel-associated box domain defines a subfamily of eukaryotic multifingered proteins.	ZNF93 ZNF85 ZNF90	1.42e-05	8	223	3	2023909
Pubmed	Functional interaction of Parkinson's disease-associated LRRK2 with members of the dynamin GTPase superfamily.	DNM1 OPA1 DNM3	1.42e-05	8	223	3	24282027
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	FRMPD4 CUL9 CAMTA2 GANAB UBR5 VIRMA OPA1 WDR47 AKAP9 BTBD7 NISCH DNM3	1.43e-05	407	223	12	12693553
Pubmed	KAP1 facilitates reinstatement of heterochromatin after DNA replication.	CORO1C STK26 HNRNPM CLPX NPM3 CTPS2 AARS2 UBR5 FLII DDX17 RECQL IPO4 VIRMA ACTR1A ABCE1 ASNS	1.44e-05	704	223	16	29955894
Pubmed	BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression.	ACOT9 INTS1 BMS1 HNRNPM SREK1 CLPX DDOST NPM3 GANAB AHNAK AFG3L2 HSPA9 DDX17 ESYT1 RECQL FASTKD2 RFC1 IPO4 USP16 SLC1A5 OPA1 RBM39 ABCE1	1.49e-05	1318	223	23	30463901
Pubmed	Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones.	PCYT1A ACOT9 HNRNPM TSC2 CLPX DDOST NPM3 GANAB CTPS2 FBXO3 UBR5 AHNAK AFG3L2 HECTD1 HSPA9 VCP FLII DDX17 RECQL RFC1 CPT1A OPA1 RBM39 USP39	1.53e-05	1415	223	24	28515276
Pubmed	LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow.	CORO1C CLPX ITGAM GANAB HECTD1 HSPA9 FLNC DDX17 ESYT1 ASNS HELZ2	1.55e-05	344	223	11	30333137
Pubmed	Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism.	INTS1 SREBF1 TSC2 NHLRC2 SREK1 KAT2A CLPX CDK14 DDOST GANAB UBR5 HECTD1 SIN3B GINS3 GRIK2 VPS54 USP16 VIRMA RBM39 SLC6A9 BTBD7 ATIC CYB5R4	1.66e-05	1327	223	23	32694731
Pubmed	Defining human ERAD networks through an integrative mapping strategy.	EPHX1 HNRNPM GANAB USH2A VCP ESYT1 EMC9 NGLY1	1.72e-05	173	223	8	22119785
Pubmed	Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents.	MYO9A ACOT9 BMS1 HNRNPM RECQL4 AFG3L2 HSPA9 DDX17 RFC1 RBM39 ABCE1 USP39 ENO2	1.76e-05	486	223	13	30940648
Pubmed	Phosphorylation switches protein disulfide isomerase activity to maintain proteostasis and attenuate ER stress.	EPHX1 PCYT1A STK26 DDOST GANAB VCP ESYT1 SLC1A5	1.79e-05	174	223	8	32149426
Pubmed	EZH2 interacts with HP1BP3 to epigenetically activate WNT7B that promotes temozolomide resistance in glioblastoma.	EPHX1 CORO1C HNRNPM DDOST GANAB AHNAK GNAS HSPA9 VCP DDX17 CEP162 ESYT1 RBM39 ABCE1 HELZ2 ATIC ENO2	1.92e-05	803	223	17	36517590
Pubmed	Systematic analysis of human protein complexes identifies chromosome segregation proteins.	PCYT1A ACOT9 CORO1C STK26 TMEM63B CLPX BLM ERCC8 GANAB UBR5 GORASP1 AHNAK RECQL4 GNAS VCP CACNA2D1 DDX17 RBM39 ACTR1B ACTR1A USP39	1.96e-05	1155	223	21	20360068
Pubmed	Identification of Zika Virus and Dengue Virus Dependency Factors using Functional Genomics.	EPHX1 CLPX DDOST GANAB AHNAK AFG3L2 VCP ESYT1 EMC9 CPT1A OPA1 ATIC	2.04e-05	422	223	12	27342126
Pubmed	Prohibitin 1 regulates tumor cell apoptosis via the interaction with X-linked inhibitor of apoptosis protein.	HNRNPM CLPX DDOST GGCX GANAB AFG3L2 HSPA9 FLNC DDX17 SLC1A5 OPA1 RBM39 RAB34 TRABD MTR USP39	2.06e-05	725	223	16	27025967
Pubmed	Aberrant splicing caused by the insertion of the B2 sequence into an intron of the complement C4 gene is the basis for low C4 production in H-2k mice.	HLA-G C4A C4B	2.12e-05	9	223	3	1373139
Pubmed	Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.	ACOT9 CORO1C BMS1 HNRNPM DDOST AHNAK AFG3L2 GNAS HSPA9 FLII DDX17 DSC1 ESYT1 RECQL RFC1 IPO4 USP16 VIRMA RBM39 ACTR1A HELZ2 USP39	2.21e-05	1257	223	22	36526897
Pubmed	MYC multimers shield stalled replication forks from RNA polymerase.	CORO1C BMS1 HNRNPM SREK1 NPM3 BLM AHNAK HSPA9 VCP FLNC DDX17 DSC1 ESYT1 RECQL RFC1 IPO4 SLC1A5 RBM39 USP39	2.36e-05	989	223	19	36424410
Pubmed	Perlecan regulates pericyte dynamics in the maintenance and repair of the blood-brain barrier.	ITGA9 ITGAM ITGAV ITGA8	2.57e-05	27	223	4	31541017
Pubmed	The Activation-Induced Assembly of an RNA/Protein Interactome Centered on the Splicing Factor U2AF2 Regulates Gene Expression in Human CD4 T Cells.	HNRNPM GANAB AHNAK HSPA9 VCP DDX17 ESYT1 VIRMA ATIC	2.63e-05	239	223	9	26641092
Pubmed	Identification of new putative susceptibility genes for several psychiatric disorders by association analysis of regulatory and non-synonymous SNPs of 306 genes involved in neurotransmission and neurodevelopment.	RELN TSC2 ADRB1 NTRK1 GRIK2 GRIK4 SLC1A7 SLC6A9 AKAP9 GABBR1	2.67e-05	300	223	10	19086053
Pubmed	R2TP/Prefoldin-like component RUVBL1/RUVBL2 directly interacts with ZNHIT2 to regulate assembly of U5 small nuclear ribonucleoprotein.	TSC2 SREK1 CLPX FBXO3 DDX17 ESYT1 SLC1A5 RBM39 EHHADH USP39	2.67e-05	300	223	10	28561026
Pubmed	The phosphorylation status of T522 modulates tissue-specific functions of SIRT1 in energy metabolism in mice.	SREBF1 CPT1A LIPE EHHADH	3.45e-05	29	223	4	28364022
Pubmed	Discovery of a Human Testis-specific Protein Complex TEX101-DPEP3 and Selection of Its Disrupting Antibodies.	EPHX1 CUL9 ITGAM DDOST VCP IPO4 ACTR1A ABCE1 ATIC	3.62e-05	249	223	9	30097533
Pubmed	mTORC2 interactome and localization determine aggressiveness of high-grade glioma cells through association with gelsolin.	ACOT9 HNRNPM CLPX AARS2 AHNAK HSPA9 VCP FLNC CPT1A ACTR1A	3.72e-05	312	223	10	37120454
Pubmed	Comparative interactome analysis of α-arrestin families in human and Drosophila.	CUL9 TSC2 CLPX GNAS CACNA2D1 FLNC EPB41L4B LAMB2 IPO4 MTR	3.82e-05	313	223	10	38270169
Pubmed	Regulation of error-prone translesion synthesis by Spartan/C1orf124.	UBR5 HSPA9 DDX17 RFC1 RBM39	3.91e-05	59	223	5	23254330
Pubmed	Enhanced analysis of the mouse plasma proteome using cysteine-containing tryptic glycopeptides.	CES1 HLA-G C4A C4B PZP	3.91e-05	59	223	5	17330941
Pubmed	Evaluation of candidate genes for cholinesterase activity in farmworkers exposed to organophosphorus pesticides: association of single nucleotide polymorphisms in BCHE.	CYP2C8 CES1 PON3 CES3	3.96e-05	30	223	4	20529763
Pubmed	Association of 14-3-3 proteins to beta1-adrenergic receptors modulates Kv11.1 K+ channel activity in recombinant systems.	ADRB1 KCNH2	4.09e-05	2	223	2	16914520
Pubmed	High-throughput analysis of the C4 polymorphism by a combination of MLPA and isotype-specific ELISA's.	C4A C4B	4.09e-05	2	223	2	19062096
Pubmed	Antigen-induced B cell apoptosis is independent of complement C4.	C4A C4B	4.09e-05	2	223	2	17645767
Pubmed	Anti-DNA autoreactivity in C4-deficient mice.	C4A C4B	4.09e-05	2	223	2	12207352
Pubmed	Development of vascular renin expression in the kidney critically depends on the cyclic AMP pathway.	GNAS REN	4.09e-05	2	223	2	19261741
Pubmed	Complement C4A and C4B Gene Copy Number Study in Alzheimer's Disease Patients.	C4A C4B	4.09e-05	2	223	2	27758680
Interaction	HAX1 interactions	TSC2 TYRO3 RECQL4 AFG3L2 GNAS DNM1 HSPA9 VCP FLII NTRK1 DPYSL4 VIRMA OPA1 ABCE1 TRABD NISCH MTR	2.51e-06	404	221	17	int:HAX1
Interaction	PTPRO interactions	CORO1C HLA-G DDOST B3GAT3 GANAB VCP LAMB2 DPYSL4 RAB34 NGLY1	4.11e-06	143	221	10	int:PTPRO
Interaction	DNAJC10 interactions	DDOST ITFG1 GANAB RECQL4 HECTD1 HSPA9 HSPB8 VCP FLT3 NTRK1 LAMB2 PTPRU AKAP9	6.33e-06	260	221	13	int:DNAJC10
Interaction	CDK2 interactions	CORO1C HNRNPM KAT2A KAT2B GANAB GORASP1 AHNAK RECQL4 HSPA9 VCP FLII FLNC DDX17 DSC1 ESYT1 NTRK1 BTBD2 RFC1 ASNS PRKCH ATIC MAP2K5 ENO2	1.80e-05	783	221	23	int:CDK2
Interaction	IRF2BPL interactions	NPM3 IRF2BPL DNM1 NTRK1 VIRMA RBM39	2.43e-05	53	221	6	int:IRF2BPL
Interaction	SIRT7 interactions	INTS1 BMS1 CUL9 BLM KAT2B GANAB UBR5 AHNAK HECTD1 HSPA9 VCP FLNC RECQL RFC1 IPO4 VIRMA RBM39 ABCE1 ASNS HELZ2 ATIC USP39	2.50e-05	744	221	22	int:SIRT7
Interaction	CPEB3 interactions	VIRMA CPEB4 NEURL1	2.54e-05	6	221	3	int:CPEB3
Interaction	ARHGAP24 interactions	ZNF93 CORO1C HNRNPM CLPX GANAB ZNF506 HSPA9 VCP DDX17 ZNF680 SLC1A5 OPA1 RBM39 ABCE1 ATIC USP39 ENO2	2.79e-05	486	221	17	int:ARHGAP24
Interaction	TMEM9B interactions	EPHX1 SREBF1 TMEM63B CTPS2 DNM1 ESYT1 ARFGEF1 DNM3	3.09e-05	111	221	8	int:TMEM9B
Interaction	CTNNB1 interactions	CORO1C HNRNPM KAT2A ITFG1 TYRO3 KAT2B GANAB UBR5 FER IRF2BPL HECTD1 HSPA9 VCP FLII FLT3 DDX17 NTRK1 ARFGEF1 GRIK2 PTPRU VIRMA RBM39 ABCE1 ATIC USP39 CDH16	4.73e-05	1009	221	26	int:CTNNB1
Interaction	MSH6 interactions	BLM GANAB UBR5 RECQL4 HECTD1 FLII NTRK1 ARFGEF1 RECQL RFC1 VIRMA ACTR1A	4.77e-05	271	221	12	int:MSH6
Interaction	IGHA2 interactions	MATN2 CDK14 PMEPA1 JAK2 DDX17 ZNF695 DNAH17	4.82e-05	87	221	7	int:IGHA2
Interaction	C9orf72 interactions	STK26 INTS1 HNRNPM RHBDD2 TSC2 CLPX DDOST GGCX GANAB CTPS2 UBR5 AFG3L2 GNAS HECTD1 HSPA9 VCP FLII DDX17 DSC1 ESYT1 BTAF1 RFC1 CPT1A IPO4 SLC1A5 OPA1 RBM39 ACTR1A ABCE1 ASNS MTR	4.88e-05	1319	221	31	int:C9orf72
Interaction	RHOB interactions	ATP7A MYO9A ACOT9 CORO1C BMS1 TSC2 ITGAV GANAB AFG3L2 GNAS HSPA9 VCP ESYT1 RALGAPA2 SLC1A5 OPA1 SLC6A9 RAB34 TRABD NISCH ASNS PRKCH SLC16A7	5.35e-05	840	221	23	int:RHOB
Interaction	WARS1 interactions	ACOT9 HNRNPM PTCH1 GANAB CTPS2 HSPA9 FLNC NTRK1 ABCE1 TATDN1	6.64e-05	197	221	10	int:WARS1
Interaction	PSMD12 interactions	ALDH1L1 PTCH1 ITGAV RECQL4 HECTD1 HSPA9 VCP FLNC PTPRU PAAF1 VIRMA RBM39 NLRP9	7.90e-05	331	221	13	int:PSMD12
Interaction	NCAPG interactions	PRMT8 B3GAT3 RECQL4 HECTD1 VCP FLII NTRK1 IPO4 VIRMA ACTR1A	8.18e-05	202	221	10	int:NCAPG
Interaction	ABHD14A interactions	PTCH1 HSPA9 GINS3 CD1E TRABD DKKL1	8.53e-05	66	221	6	int:ABHD14A
Interaction	VDAC2 interactions	TMEM63B CUL9 ITGAV DDOST GANAB AHNAK RECQL4 PZP VCP NTRK1 CPT1A VIRMA RBM39 AKAP9 ABCE1	9.02e-05	432	221	15	int:VDAC2
Interaction	LARS1 interactions	ITFG1 SERPINB8 RECQL4 TAF2 HECTD1 HSPA9 FLII FLNC FLT3 NTRK1 EMC9 VIRMA ABCE1 ASNS	9.05e-05	383	221	14	int:LARS1
Interaction	KARS1 interactions	CORO1C ITGAM ITFG1 AARS2 RECQL4 HECTD1 HSPA9 VCP FLNC FLT3 NTRK1 EMC9 VIRMA ABCE1	9.05e-05	383	221	14	int:KARS1
Interaction	SPRTN interactions	ACOT9 HNRNPM NHLRC2 CTPS2 UBR5 RECQL4 AFG3L2 HSPA9 VCP DDX17 RFC1 CPT1A RALGAPA2 SLC1A5 RBM39 ABCE1 NISCH ASNS	1.08e-04	596	221	18	int:SPRTN
Interaction	PHB1 interactions	CORO1C HNRNPM TMEM63B CLPX PTCH1 DDOST GGCX ITFG1 GANAB AARS2 UBR5 RECQL4 AFG3L2 HSPA9 VCP FLNC DDX17 NTRK1 CPT1A VIRMA SLC1A5 OPA1 RBM39 RAB34 TRABD MTR USP39	1.08e-04	1123	221	27	int:PHB1
Interaction	PYCR2 interactions	AARS2 AHNAK RECQL4 HSPA9 VCP CEP162 NTRK1 FASTKD2 SLC1A5 CRYZ	1.08e-04	209	221	10	int:PYCR2
Interaction	CTPS1 interactions	CTPS2 UBR5 RECQL4 HSPA9 VCP GINS3 DDX17 NTRK1 VIRMA RBM39 ABCE1	1.12e-04	252	221	11	int:CTPS1
Interaction	LMBR1L interactions	STK26 HNRNPM TSC2 DDOST B3GAT3 GPR180 GANAB CTPS2 AARS2 UBR5 HECTD1 VCP ESYT1 ARFGEF1 BTAF1 CPT1A IPO4 SLC1A5 OPA1 TRABD NISCH ASNS MTR ATIC	1.19e-04	946	221	24	int:LMBR1L
Interaction	CCDC8 interactions	INTS1 CUL9 AARS2 UBR5 AHNAK RECQL4 AFG3L2 GNAS HECTD1 HSPA9 VCP FLII CACNA2D1 DDX17 AFF3 LAMB2 BTAF1 SLC1A5 USP39	1.19e-04	656	221	19	int:CCDC8
Interaction	FBXO6 interactions	ACOT9 HNRNPM CLPX ITGAV PTGS1 DDOST GGCX ITFG1 CILP2 GANAB AFG3L2 HSPA9 VCP DDX17 LAMB2 PTPRU CPT1A SLC1A5 ABCE1 NGLY1	1.31e-04	717	221	20	int:FBXO6
Interaction	EIF4A3 interactions	INTS1 BMS1 HNRNPM CUL9 BLM CTPS2 UBR5 RECQL4 HECTD1 HSPA9 FLII DDX17 NTRK1 BTAF1 RBM39 ABCE1	1.33e-04	499	221	16	int:EIF4A3
Interaction	DYRK1A interactions	PCYT1A TMEM63B TSC2 AHNAK DNM1 HSPB8 FLNC NTRK1 VPS54 VIRMA SLC1A5 OPA1 RBM39 WDR47 ACTR1A ABCE1 DNM3	1.33e-04	552	221	17	int:DYRK1A
Interaction	CTTNBP2NL interactions	STK26 NHLRC2 GANAB FLNC NTRK1 VIRMA	1.39e-04	72	221	6	int:CTTNBP2NL
Interaction	MCM2 interactions	MYO9A HNRNPM CLPX DDOST NPM3 SERPINB8 GANAB FBXO3 UBR5 AHNAK RECQL4 C4A C4B HSPA9 VCP FLNC GINS3 DDX17 DSC1 NTRK1 FASTKD2 VIRMA SLC1A5 OPA1 RBM39 ABCE1	1.45e-04	1081	221	26	int:MCM2
Interaction	HERC2 interactions	CORO1C NHLRC2 SREK1 BLM TAF2 GNAS HECTD1 FLII CEP162 SIPA1 CPT1A USP16 VIRMA RBM39 RAB34 AKAP9	1.45e-04	503	221	16	int:HERC2
Interaction	MAT2A interactions	HNRNPM AARS2 RECQL4 HSPA9 VCP FLNC NTRK1 VIRMA RBM39 ASNS	1.53e-04	218	221	10	int:MAT2A
Interaction	HOMER1 interactions	MATN2 STK26 NHLRC2 RYR1 DNM1 VIRMA DNM3 CSPP1	1.59e-04	140	221	8	int:HOMER1
Interaction	RTRAF interactions	MYO9A ITFG1 AHNAK RECQL4 HECTD1 FLII NTRK1 RBM39 ABCE1 CPEB4	1.78e-04	222	221	10	int:RTRAF
Interaction	SLC25A3 interactions	RHBDD2 CUL9 DDOST ITFG1 TYRO3 UBR5 RECQL4 AFG3L2 VCP FLNC NTRK1 VIRMA ELAVL3 MAP2K5	1.89e-04	411	221	14	int:SLC25A3
Interaction	NPNT interactions	MATN2 FLT3 ITGA8	2.01e-04	11	221	3	int:NPNT
Interaction	BTBD7 interactions	RECQL4 VIRMA BTBD7	2.01e-04	11	221	3	int:BTBD7
Interaction	ISOC1 interactions	STK26 CUL9 RECQL4 NTRK1 ASNS ATIC	2.01e-04	77	221	6	int:ISOC1
Interaction	GARS1 interactions	CORO1C HNRNPM GANAB AARS2 RECQL4 HSPA9 VCP NTRK1 VIRMA RBM39 ASNS	2.04e-04	270	221	11	int:GARS1
Interaction	KPNA2 interactions	PCYT1A PTCH1 GANAB UBR5 RECQL4 HECTD1 FLII NTRK1 TRIM54 LAMB2 RECQL BTBD2 VIRMA RBM39 ACTR1A NGLY1	2.07e-04	519	221	16	int:KPNA2
Interaction	CDK9 interactions	CORO1C STK26 INTS1 BMS1 HNRNPM DDOST NPM3 GANAB UBR5 RECQL4 TAF2 HSPA9 FLII DDX17 AFF3 RECQL OPA1 RBM39 ASNS	2.07e-04	685	221	19	int:CDK9
Interaction	CCT7 interactions	STK26 ITGAM ITFG1 ERCC8 RECQL4 HECTD1 VCP FLNC GALNT10 NTRK1 RECQL VIRMA RBM39 ACTR1B ACTR1A TATDN1 MAP2K5	2.15e-04	575	221	17	int:CCT7
Interaction	MRPS28 interactions	HNRNPM CUL9 ITFG1 AARS2 RECQL4 FLT3 NEIL1 FASTKD2 RBM39 CRYZ	2.20e-04	228	221	10	int:MRPS28
Interaction	ARFGEF1 interactions	STK26 HNRNPM NHLRC2 NTRK1 ITGA8 ARFGEF1 IPO4 VIRMA	2.23e-04	147	221	8	int:ARFGEF1
Interaction	MRPS17 interactions	MYO9A NPM3 ITFG1 AARS2 RECQL4 NEIL1 FASTKD2 RBM39 CRYZ NISCH	2.28e-04	229	221	10	int:MRPS17
Interaction	ACTR1A interactions	GANAB UBR5 RECQL4 VCP FLII NTRK1 VIRMA RBM39 ACTR1B ACTR1A EHHADH	2.32e-04	274	221	11	int:ACTR1A
Interaction	NARS1 interactions	CORO1C ITGAM GANAB AARS2 NTRK1 VIRMA RBM39 ASNS	2.44e-04	149	221	8	int:NARS1
Interaction	RBM25 interactions	HNRNPM TMEM63B SREK1 UBR5 TAF2 HECTD1 VCP FLII NTRK1 VIRMA RBM39 ACTR1A	2.48e-04	323	221	12	int:RBM25
Interaction	SGCA interactions	GGCX B3GAT3 ITFG1 GPR180 CTPS2 ARFGEF1 PTPRU	2.50e-04	113	221	7	int:SGCA
Interaction	ACAT1 interactions	AARS2 RECQL4 VCP NTRK1 FASTKD2 VIRMA RBM39 CRYZ ABCE1 PDP1	2.53e-04	232	221	10	int:ACAT1
Interaction	PLD6 interactions	ACOT9 GANAB MICB ESYT1 CPT1A OPA1 RAB34 TRABD	2.67e-04	151	221	8	int:PLD6
Interaction	DDOST interactions	CUL9 DDOST ITFG1 TYRO3 RECQL4 HECTD1 VCP FLT3 ESYT1 NTRK1 RECQL PTPRU VIRMA	2.70e-04	375	221	13	int:DDOST
Interaction	ENO1 interactions	HNRNPM ITGAM UBR5 AHNAK RECQL4 HSPA9 VCP AMBP FLNC NTRK1 CPT1A IPO4 VIRMA RBM39 RAB34 PDP1 TRABD MAP2K5 ENO2	2.77e-04	701	221	19	int:ENO1
Interaction	A2M interactions	CYP2C8 MATN2 CUL9 TYRO3 PZP AMBP RECQL ELAVL3 ENO2	2.78e-04	192	221	9	int:A2M
Cytoband	19p12	ZNF93 ZNF626 ZNF66 ZNF737 ZNF85 ZNF90	5.44e-06	90	223	6	19p12
Cytoband	7q21-q22	CDK14 CACNA2D1 AKAP9	1.32e-05	10	223	3	7q21-q22
Cytoband	Ensembl 112 genes in cytogenetic band chr19p12	ZNF93 ZNF626 ZNF66 ZNF737 ZNF85 ZNF90	3.10e-05	122	223	6	chr19p12
Cytoband	19p13.11	CILP2 ZNF506 SIN3B ZNF253	4.54e-04	73	223	4	19p13.11
GeneFamily	RecQ like helicases	BLM RECQL4 RECQL	6.59e-06	5	159	3	1049
GeneFamily	CD molecules\|Integrin alpha subunits	ITGA9 ITGAM ITGAV ITGA8	1.60e-05	18	159	4	1160
GeneFamily	C3 and PZP like, alpha-2-macroglobulin domain containing	C4A C4B PZP	5.39e-05	9	159	3	1234
GeneFamily	Fibronectin type III domain containing\|USH2 complex	ADGRV1 USH2A	4.56e-04	4	159	2	1244
GeneFamily	Glutamate ionotropic receptor kainate type subunits	GRIK2 GRIK4	7.55e-04	5	159	2	1199
GeneFamily	Carboxylesterases	CES1 CES3	7.55e-04	5	159	2	461
GeneFamily	Solute carriers	SLC36A1 SLC25A26 SLC37A2 SLC1A5 SLC1A7 SLC2A5 SLC6A9 SLC9A3 SLC18A1 SLC22A3 SLC16A7	7.59e-04	395	159	11	752
GeneFamily	Armadillo repeat containing\|Protein phosphatase 1 regulatory subunits	TSC2 PPP1R3G RYR1 FER VDR VPS54 AKAP9	1.12e-03	181	159	7	694
GeneFamily	AAA ATPases	CLPX AFG3L2 VCP RFC1	1.21e-03	53	159	4	413
GeneFamily	Acyl-CoA thioesterases	ACOT9 ACOT12	3.30e-03	10	159	2	41
GeneFamily	Complement system\|Sushi domain containing	ITGAM C4A C4B	3.85e-03	36	159	3	492
Coexpression	GSE9037_CTRL_VS_LPS_1H_STIM_BMDM_DN	MYO9A ACOT9 NPM3 JAK2 PLA2G4F ITGA8 GRIK4 RBM39 NISCH HELZ2 ADAP2	1.26e-06	200	223	11	M5801
Coexpression	PEREZ_TP53_TARGETS	CES1 TSC2 ALDH1L1 ADGRV1 ITGA9 ITGAM ITGAV BTG2 ELAPOR1 IRF2BPL C4A GNAS VDR FLNC GALNT10 EPB41L4B AFF3 TP53I11 MFSD9 DPYSL4 WDR47 ECHDC3 AKAP9 EHHADH CES3 ENO2 ADAP2	4.29e-06	1201	223	27	M4391
Coexpression	SILIGAN_TARGETS_OF_EWS_FLI1_FUSION_DN	CDK14 RFC1 SLC2A5 ASNS	1.42e-05	18	223	4	M16533
Coexpression	HAMAI_APOPTOSIS_VIA_TRAIL_UP	MYO9A MATN2 SREK1 ITGAV ITFG1 BLM FER HECTD1 ARFGEF1 RECQL RFC1 OPA1 BTBD7 MTR ZNF85 TATDN1 CSPP1 SLC16A7	1.44e-05	656	223	18	M18979
Coexpression	MARTINEZ_RB1_TARGETS_UP	EPHX1 PCYT1A HLA-G FBP2 SREK1 ITGA9 ITGAV PMEPA1 RYR1 GNAS HSPA9 CACNA2D1 OSR2 PON3 RECQL RFC1 OPA1 LIPE ABCE1	2.12e-05	741	223	19	MM1037
Coexpression	MARTINEZ_RB1_AND_TP53_TARGETS_UP	PCYT1A FBP2 ITGA9 ITGAV PMEPA1 NPM3 GNAS HSPA9 CACNA2D1 OSR2 PON3 RECQL RFC1 VIRMA SLC1A5 OPA1 LIPE	2.69e-05	623	223	17	M15896
Coexpression	MARTINEZ_RB1_AND_TP53_TARGETS_UP	PCYT1A HLA-G FBP2 ITGA9 ITGAV PMEPA1 NPM3 GNAS HSPA9 CACNA2D1 OSR2 PON3 RECQL RFC1 VIRMA SLC1A5 OPA1 LIPE	2.76e-05	689	223	18	MM1041
Coexpression	MARTINEZ_RB1_TARGETS_UP	EPHX1 PCYT1A FBP2 SREK1 ITGA9 ITGAV PMEPA1 RYR1 GNAS HSPA9 CACNA2D1 OSR2 PON3 RECQL RFC1 OPA1 LIPE ABCE1	2.81e-05	690	223	18	M12224
Coexpression	PRC2_EED_DN.V1_DN	TSC2 RECQL4 FER AFF3 BTBD2 SIPA1 LIPE BTBD7 ENO2	4.35e-05	193	223	9	M2734
Coexpression	GSE25088_CTRL_VS_IL4_AND_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_UP	PCYT1A TSC2 ITGAM DDX17 ESYT1 AKAP9 ABCE1 BTBD7 CES3	5.11e-05	197	223	9	M8022
Coexpression	GSE12845_PRE_GC_VS_DARKZONE_GC_TONSIL_BCELL_DN	CLPX BLM CTPS2 UBR5 NEIL1 ARFGEF1 BTAF1 RFC1 RBM39	5.52e-05	199	223	9	M3204
Coexpression	GSE42021_TREG_VS_TCONV_PLN_DN	PRMT8 TYRO3 AHNAK HSPB8 GALNT10 EPB41L4B EMC9 ACTR1B ENO2	5.52e-05	199	223	9	M9574
Coexpression	GSE17721_LPS_VS_POLYIC_4H_BMDC_DN	PCYT1A PDCD2 SREBF1 CAMTA2 MEA1 GPR180 AFG3L2 CPT1A ACTR1A	5.52e-05	199	223	9	M3807
ToppCell	TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Non-Papillary_Muscle_Invasive_Urothelial_Carcinoma-8\|TCGA-Bladder / Sample_Type by Project: Shred V9	GORASP1 ZNF680 MFSD9 RALGAPA2 ZNF253 ZNF66 ZNF737 NGLY1	9.23e-07	150	223	8	1aa9320d97ff10994ea024751790524fe133aba9
ToppCell	TCGA-Bile_Duct-Primary_Tumor-Cholangiocarcinoma-Intrahepatic-2\|TCGA-Bile_Duct / Sample_Type by Project: Shred V9	MYO9A PTCH1 ITGAM ITGAV PTGS1 FASTKD2 MTR MAP2K5	2.16e-06	168	223	8	c70bf73bb800e4722cedc35bbc17ea3113d1012d
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D231\|Adult / Lineage, Cell type, age group and donor	SECISBP2L PRMT8 ADGRV1 ITGA9 CDK14 ELAPOR1 DSC1 SLC22A3	2.36e-06	170	223	8	269dee5abca9f6aa079f116f0d8f1d198604d9d4
ToppCell	facs-Brain_Non-Myeloid-Cortex_-18m-Myeloid-microglial_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ITGAM PTGS1 SLC37A2 PON3 SLC2A5 RAB34 MTR ADAP2	2.81e-06	174	223	8	8d6df5938cef542f23259ce471eea1a1afbed03c
ToppCell	facs-Brain_Non-Myeloid-Cortex_-18m-Myeloid\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ITGAM PTGS1 SLC37A2 PON3 SLC2A5 RAB34 MTR ADAP2	2.81e-06	174	223	8	2af54c3427aacfa232e2aca6003b4a8ecb8bba66
ToppCell	facs-Brain_Non-Myeloid-Cortex_-18m-Myeloid-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ITGAM PTGS1 SLC37A2 PON3 SLC2A5 RAB34 MTR ADAP2	2.81e-06	174	223	8	eca643b8f5b92aeed5a77c94b4301fd8100f9401
ToppCell	Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_granulocytic-mast_cell\|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	RHBDD2 ITGA9 ITGAV PTGS1 FER NTRK1 SLC1A5 CPEB4	4.42e-06	185	223	8	3fafb1d36c5f98a29d20a5ce5192c83d6f603514
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)\|Adult / Lineage, Cell type, age group and donor	SECISBP2L ADGRV1 ITGA9 CDK14 ELAPOR1 AFF3 PON3 SLC22A3	4.42e-06	185	223	8	673f0c688ae6984bc8027df2da335787924f4137
ToppCell	droplet-Heart-HEART-1m-Neuronal-nan\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN MATN2 XYLT1 PCDHGB6 EPB41L4B DPYSL4 GRIK4 SLC22A3	4.60e-06	186	223	8	fddc6b93f98b10aaf8d4ebc142b46d8213f3129d
ToppCell	Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_granulocytic\|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	RHBDD2 ITGA9 ITGAV PTGS1 FER CACNA2D1 NTRK1 CPEB4	4.60e-06	186	223	8	de55471dd5c842026b409cfebf67fe32f079a011
ToppCell	Control_saline-Epithelial_alveolar-AT_2-Differentiating_AT2\|Control_saline / Treatment groups by lineage, cell group, cell type	SECISBP2L EPHX1 TMEM63B ADGRV1 PTPRU AKAP9 PLA2G4B SLC22A3	7.01e-06	197	223	8	44a59dfb889577b3160a5b13ada1276771a00241
ToppCell	COVID-19_Severe-cDC\|COVID-19_Severe / Disease condition and Cell class	DDOST RYR1 FLT3 ESYT1 AFF3 CD1E ABCE1 ATIC	7.28e-06	198	223	8	e0b16627a347e245bedd71b1e0ccdb46c1c1bd6d
ToppCell	COVID-19_Severe-cDC-\|COVID-19_Severe / Disease condition and Cell class	DDOST RYR1 FLT3 ESYT1 AFF3 CD1E ABCE1 ATIC	7.28e-06	198	223	8	3914140238598914674c08c5ad83354b9485825f
ToppCell	(1)_Osterolineage_cells-(11)_OLC-2\|(1)_Osterolineage_cells / Cell class and subclass of bone marrow stroma cells in homeostatis	MATN2 CILP2 AHNAK DNM1 HSPB8 PDZRN4 AFF3 OSR2	7.28e-06	198	223	8	9f9dcf23ffb333105263132d87b90095642294cf
ToppCell	kidney_cells-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	MATN2 GANAB AHNAK DDX17 RBM39 VPS13D AKAP9 SLC16A7	7.55e-06	199	223	8	174f6013af6eafa577f84205a62927f2b367fda3
ToppCell	Neuronal-Inhibitory-iB-iB_4(SST)-ADGRG6-\|Neuronal / cells hierarchy compared to all cells using T-Statistic	RELN CABP5 ITGA9 BLM FLT3 GRIK2 PTPRU RAB34	7.83e-06	200	223	8	a9cdddc4e985dae59521e557479c24fcc2ac727d
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	SREK1 JAK2 AHNAK DDX17 BTAF1 RBM39 AKAP9 HELZ2	7.83e-06	200	223	8	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	Neuronal-Inhibitory-iB-iB_4(SST)-ADGRG6\|Neuronal / cells hierarchy compared to all cells using T-Statistic	RELN CABP5 ITGA9 BLM FLT3 GRIK2 PTPRU RAB34	7.83e-06	200	223	8	9719fabddc34051949468a7520289e3c750de4f8
ToppCell	Neuronal-Inhibitory-iB-iB_4(SST)-ADGRG6--L3-5\|Neuronal / cells hierarchy compared to all cells using T-Statistic	RELN CABP5 ITGA9 BLM FLT3 GRIK2 PTPRU RAB34	7.83e-06	200	223	8	33b9199e0dfc267e2cea20b82d1c167f8adcc635
ToppCell	tumor_Lung-Myeloid_cells-Pleural_Mac\|Myeloid_cells / Location, Cell class and cell subclass	AARS2 FBXO3 PLA2G4F FLT3 ZNF680 CD1E LIPE	9.05e-06	146	223	7	8b2d104fdb0fdb09410450c6c651e1edb00cae44
ToppCell	COVID-19-kidney-Technical/muscle_(Mes)\|kidney / Disease (COVID-19 only), tissue and cell type	RELN KCNH7 RYR1 USH2A PDZRN4 GALNTL6 GRIK4	1.58e-05	159	223	7	5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d
ToppCell	NS-critical-LOC-Myeloid-Basophil\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	ITGA9 TYRO3 CTPS2 KCNH2 DNM1 DNTT NTRK1	1.64e-05	160	223	7	8a4746463ca1976f7d6de803496c851249ced797
ToppCell	E18.5-Immune-Immune_Myeloid-DC-cDC1-cDC1_mature\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FLNC FLT3 NEIL1 LIPE TRABD DKKL1 SP140	1.78e-05	162	223	7	388670cf3acef17df971c0d8ae3ce14398945192
ToppCell	E18.5-Immune-Immune_Myeloid-DC-cDC1\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FLNC FLT3 NEIL1 LIPE TRABD DKKL1 SP140	1.78e-05	162	223	7	9333d923225df7bfdf6b3a4c32816751315aec50
ToppCell	COVID-19-lung-MAST\|lung / Disease (COVID-19 only), tissue and cell type	ITGA9 PTGS1 KCNH2 FER PZP CACNA2D1 NTRK1	2.42e-05	170	223	7	e90f18e5462381b38e918442b38b1c8105291908
ToppCell	Control-Myeloid-Mast\|Control / Disease state, Lineage and Cell class	ITGA9 PTGS1 KCNH2 FER PZP CACNA2D1 NTRK1	2.42e-05	170	223	7	9a14deb7f7cd4a49c217eba4023f7bf1dec6c902
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	GNAS PDZRN4 TP53I11 ITGA8 GRIK2 REN ADGRA2	2.42e-05	170	223	7	cdb6fad277f284c3fd5a6f45672a8edc24715882
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell-Renin-positive_Juxtaglomerular_Granular_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	GNAS PDZRN4 TP53I11 ITGA8 GRIK2 REN ADGRA2	2.42e-05	170	223	7	99dd734c0972a40d5381e8e2d96bdaa31f6d06e6
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	GNAS PDZRN4 TP53I11 ITGA8 GRIK2 REN ADGRA2	2.42e-05	170	223	7	3a14eeae221b8bb0bd0dadcb8e7a603431240a1e
ToppCell	Control-Myeloid-Mast\|World / Disease state, Lineage and Cell class	ITGA9 PTGS1 KCNH2 FER PZP CACNA2D1 NTRK1	2.52e-05	171	223	7	ed8e61d524f4cddc6084b261175df54d2a64a60f
ToppCell	facs-Marrow-KLS-18m-Myeloid-promonocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO9A CDK14 JAK2 FLT3 ADGRA2 RAB34 ADAP2	2.61e-05	172	223	7	979fd7b435f59b8a4d290a809cf76147d4c63d48
ToppCell	facs-Marrow-KLS-18m-Myeloid-monocyte_+_promonocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO9A CDK14 JAK2 FLT3 ADGRA2 RAB34 ADAP2	2.61e-05	172	223	7	f4d7f416802218ce56408fa4cb8a555d846bc85b
ToppCell	facs-Marrow-B-cells-24m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EPHX1 ADGRV1 USH2A FGF19 PDZRN4 DSC1 GRIK2	2.92e-05	175	223	7	887e75fc90e59a6394d62f3c048a9cfdf6707725
ToppCell	Control-Myeloid-Mast\|Myeloid / Disease state, Lineage and Cell class	ITGA9 PTGS1 KCNH2 FER PZP CACNA2D1 NTRK1	3.03e-05	176	223	7	0c5916d63e1ada09105e46d2429b75129b7329ec
ToppCell	facs-Marrow-Granulocytes-24m-Hematologic-MPP_Fraction_B\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ITGAV SERPINB8 SLC37A2 DNM1 PON3 SLC2A5 RAB34	3.14e-05	177	223	7	4a697866ed542d3201714234cee03451adf1dcc9
ToppCell	facs-Brain_Non-Myeloid-Striatum-24m-Neuronal\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRPM2 RYR1 ELAPOR1 DNM1 GRIK2 ENO2 GABBR1	3.37e-05	179	223	7	a3922476f33d2e4137a12dbda21a1703dff79684
ToppCell	TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Cervical_Squamous_Cell_Carcinoma-3\|TCGA-Cervix / Sample_Type by Project: Shred V9	SLC36A1 SLC37A2 PLA2G4F VDR BTAF1 VPS13D	3.47e-05	122	223	6	1ed865f0ecfe304fb86313ff51c04e9052357270
ToppCell	Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Igfbp4\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	CABP5 RECQL4 HS3ST2 USH2A TMEM102	3.49e-05	74	223	5	08874e430b4c9fcb2c1758c4178cb0c45671b125
ToppCell	Children_(3_yrs)-Epithelial-club_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	PRMT8 ADGRV1 ITGA9 CDK14 ELAPOR1 GRIK2 SLC22A3	3.49e-05	180	223	7	b509c7d6bdfba672065fb722874bdc68de72ba1c
ToppCell	normal_Lung-Myeloid_cells-CD207+CD1a+_LCs\|normal_Lung / Location, Cell class and cell subclass	TRPM2 PTGS1 AFF3 CD1E CRYZ ZNF737 ADAP2	3.62e-05	181	223	7	b55dbcfae8c92d322071906831489830a22239b9
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Neuronal-neuron_precursor-cycling_neuroblast\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ADGRV1 BLM GINS3 ZNF695 GRIK2 ARSL ENO2	3.75e-05	182	223	7	e6968e0bd9cef92052d04ac54e2dd746b37623f6
ToppCell	facs-Liver-Hepatocytes-24m\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SREBF1 C4B PZP OPLAH EHHADH CES3 SLC16A7	3.88e-05	183	223	7	d0721c6aa426953a520d40e976b6e65aa7ca65e8
ToppCell	IPF-Myeloid-Mast\|Myeloid / Disease state, Lineage and Cell class	ITGA9 PTGS1 KCNH2 FER PZP CACNA2D1 NTRK1	4.02e-05	184	223	7	7326a16d7d3ae41b8c9d2beaec7f977b374f3469
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SECISBP2L ADGRV1 ITGA9 CDK14 ELAPOR1 AFF3 SLC22A3	4.16e-05	185	223	7	98b8ee42b89d97e4c9db01740e0c193503c68f2c
ToppCell	368C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	PRMT8 HLA-G PTCH1 ELAPOR1 RAB34 HELZ2 SLC16A7	4.30e-05	186	223	7	77bebf576eb9b96ecb4fefb8a82a31aaaa917fc0
ToppCell	Thalamus-Endothelial\|Thalamus / BrainAtlas - Mouse McCarroll V32	EPHX1 AHNAK ESYT1 LAMB2 ADGRA2 SLC1A5 HELZ2	4.30e-05	186	223	7	dcc6e4417c4123d5ca6b96fa8ca4874626aaebdb
ToppCell	COVID-19-lung-Plasma_cells_PRDM1/BLIMP_hi\|lung / Disease (COVID-19 only), tissue and cell type	CDK14 BLM BTG2 RECQL4 SLC2A5 CPEB4 SP140	4.30e-05	186	223	7	66676d9395172de5707e204826a1c9f73b448cca
ToppCell	368C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	PRMT8 HLA-G PTCH1 ELAPOR1 RAB34 HELZ2 SLC16A7	4.30e-05	186	223	7	13bc41c60fd628af31899a5e8b480e06cc4781be
ToppCell	droplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l30\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MATN2 ALDH1L1 BLM KCNH2 EPB41L4B GRIK2 WDR47	4.45e-05	187	223	7	8e8b147258982b359447add5027318f5b6d51963
ToppCell	COVID-19-kidney-Mito-rich_Int\|kidney / Disease (COVID-19 only), tissue and cell type	RELN KCNH7 PDZRN4 GALNTL6 CD1E OR11A1	4.75e-05	129	223	6	57b705106aec7bbfc587de1ccd4f2335fc44dd6f
ToppCell	368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3\|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells)	RHBDD2 SREK1 SERPINB8 GORASP1 TAF2 HSPB8 SP140	4.92e-05	190	223	7	651a1d3ae286e40f9d9f60e438211c6148d24143
ToppCell	PCW_07-8.5-Epithelial-Epithelial_neuroendo-epi_neuroendocrine1[NE1]_(11)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	KCNH7 FRMPD4 NALCN ELAPOR1 GRIK2 SLC18A1 ENO2	4.92e-05	190	223	7	b1095b2a7467c152d16e4f19a9515aeb61fc9e3d
ToppCell	facs-Aorta-Heart-3m-Mesenchymal-fibroblast\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STK26 C4B DNM1 PDZRN4 FLNC ADGRA2 SLC1A5	5.09e-05	191	223	7	9214655dca96d766737c9f30b624d7fe7050342e
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8\|lymph-node_spleen / Manually curated celltypes from each tissue	SREK1 AHNAK DDX17 ARFGEF1 BTAF1 RBM39 PRKCH	5.26e-05	192	223	7	47646d7e4990be85072987f92bf18d52f8da752e
ToppCell	390C-Myeloid-Mast_cell\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	PTGS1 BTG2 KCNH2 AHNAK FER NTRK1 CPEB4	5.26e-05	192	223	7	201d430af1e4fee7bc03baf0aca17db26f6f439a
ToppCell	390C-Myeloid-Mast_cell-\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	PTGS1 BTG2 KCNH2 AHNAK FER NTRK1 CPEB4	5.26e-05	192	223	7	15c1a0a0d07106118427135f166a1da710bf621a
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MYO9A ADGRV1 DDX17 SLC9A3 AKAP9 CPEB4 SLC16A7	5.26e-05	192	223	7	ee27d27e3d269764dbe8711d0b37ff9331a298a9
ToppCell	NS-moderate-d_0-4\|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	EPHX1 CES1 ADGRV1 PZP ZNF680 WDPCP CSPP1	5.44e-05	193	223	7	ea345d34440b25f65358a53dc72831998d1c3620
ToppCell	Thalamus-Neuronal\|Thalamus / BrainAtlas - Mouse McCarroll V32	KCNH7 FRMPD4 B3GAT3 KCNH2 ELAPOR1 DNM1 ENO2	5.44e-05	193	223	7	712a4acd1167e43543950bc819ff11984e6f718d
ToppCell	human_hepatoblastoma\|World / Sample and Cell Type and Tumor Cluster (all cells)	SREK1 UBR5 FER VPS54 RBM39 AKAP9 MTR	5.44e-05	193	223	7	e6a688bc834f845ff64dae1be64f073eec5091a1
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27\|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)	SECISBP2L CDK14 MFSD4B AHNAK VCP AFF3 NGLY1	5.44e-05	193	223	7	08696a99309f5b088692ddac8cca35413b5e810d
ToppCell	Children_(3_yrs)-Immune-monocyte-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	TRPM2 ITGAM PTGS1 XYLT1 JAK2 FLT3 CD1E	5.44e-05	193	223	7	58e1930a1d80ad3729ab9604ac8ebf7308232a3d
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	RELN ITGA9 BLM FLT3 GRIK2 PTPRU RAB34	5.44e-05	193	223	7	658c2b30a4d806c5ce78ea4392fe8eb86b8d1e99
ToppCell	PCW_07-8.5-Epithelial-Epithelial_neuroendo\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	PRMT8 KCNH7 ADGRV1 ELAPOR1 GRIK2 SLC18A1 ENO2	5.62e-05	194	223	7	b30379f8dc41c86c746af9930541fbb4819d8fa0
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MATN2 XYLT1 NALCN PDZRN4 AFF3 ITGA8 ADGRA2	5.80e-05	195	223	7	edd4cd8402af81737b2074f9dce71cc6ab09be7e
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MATN2 PTCH1 XYLT1 AFF3 ITGA8 GRIK4 ADGRA2	5.80e-05	195	223	7	d9a5c75d31c6e8bb1e1ab7fd115ac5deb5fb1c8d
ToppCell	Bronchial-NucSeq-Epithelial-Epi_airway_secretory\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SECISBP2L ZNF626 CDK14 ELAPOR1 GRIK2 SLC9A3 SLC22A3	5.80e-05	195	223	7	e7230a849ea31e6eef9bc6f5468938499450582d
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MATN2 ITGA9 JAK2 NALCN PDZRN4 AFF3 ITGA8	5.99e-05	196	223	7	1522958a92e0126326a9f0d9fb1c5b5c50b001ea
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MATN2 ITGA9 JAK2 NALCN PDZRN4 AFF3 ITGA8	5.99e-05	196	223	7	1c8294014713684b50885e638668f2ce75f357f0
ToppCell	distal-Hematologic-Interstitial_Macrophage-3\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	TRPM2 ITGAM SLC37A2 HS3ST2 SLC2A5 CD1E ADAP2	5.99e-05	196	223	7	e4f40274df940e0996c555082f2bb4f99e5b0881
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic-Monocyte-derived_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TRPM2 ITGAM SLC37A2 FLT3 AFF3 CD1E ADAP2	6.19e-05	197	223	7	826cc6baafab13e7ef5cfcf28cd79d0fbf3af38d
ToppCell	5'-Adult-SmallIntestine-Endothelial-lymphatic_endothelial\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	EPHX1 RELN ITGA9 NALCN HS3ST2 FLNC RALGAPA2	6.19e-05	197	223	7	407231542fa1ffd540dcb61435c0575e71f59725
ToppCell	BAL-Mild-Myeloid-MoAM\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SLC36A1 ACOT9 TRPM2 ITGAM SLC37A2 HS3ST2 ADAP2	6.19e-05	197	223	7	0f40dd3530eb8d02e79b32f942efe3b65b8f6ee6
ToppCell	BAL-Mild-Myeloid-MoAM\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	SLC36A1 ACOT9 TRPM2 ITGAM SLC37A2 HS3ST2 ADAP2	6.19e-05	197	223	7	a6aa5991d566c28440f7e24a30933e69669064f2
ToppCell	356C-Fibroblasts-Fibroblast-E\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	ADRB1 OPLAH PCDHGA6 PON3 REN ZNF253	6.37e-05	136	223	6	edfd453c9a650d69d05a5a3ab15f7df56349fa86
ToppCell	356C-Fibroblasts-Fibroblast-E-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	ADRB1 OPLAH PCDHGA6 PON3 REN ZNF253	6.37e-05	136	223	6	03e4e2353c23ceffde35b2d0aadd15299e3db09f
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Club\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PRMT8 ADGRV1 ITGA9 CDK14 ELAPOR1 GRIK2 SLC22A3	6.39e-05	198	223	7	1408e02e053ad3406229bfe8189da03be6366e81
ToppCell	Tracheal-10x5prime-Stromal-Peri/Epineurial_-NAF_endoneurial\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	MATN2 PTCH1 NALCN C4A C4B OSR2 SLC22A3	6.39e-05	198	223	7	7a0c4dbc8c99968d42af00a718f4fedc544599ec
ToppCell	Parenchymal-NucSeq-Immune_Myeloid-Macrophage_other-Macro_AW_CX3CR1\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TRPM2 PTGS1 BLM RECQL4 DSC1 SLC18A1 ADAP2	6.39e-05	198	223	7	732a43061d75bc5e1cf23f5056b72cd10c926668
ToppCell	Tracheal-10x5prime-Stromal-Peri/Epineurial_-NAF_epineurial\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	MATN2 NALCN C4B PDZRN4 WDR47 SLC22A3 DNM3	6.59e-05	199	223	7	fbec5c034576cb1adaf05f6f97cc5525d19e0c1b
ToppCell	LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	MATN2 PTCH1 ITGA9 KCNH2 PZP LAMB2 RAB34	6.59e-05	199	223	7	e9820d5fb4e8b46973c4c50ac5db8fb4a1bf603b
ToppCell	Tracheal-NucSeq-Immune_Myeloid-Macrophage_other-Macro_AW_CX3CR1\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TRPM2 ITGAM PTGS1 RYR1 SIPA1 SLC2A5 ADAP2	6.59e-05	199	223	7	744b63fba33b176ab7dde11646ccb313665505f7
ToppCell	mild-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	SREK1 DDX17 ARFGEF1 BTAF1 RBM39 AKAP9 PRKCH	6.59e-05	199	223	7	f0b0097df0026496470a80d8cc9375ffd8389b00
ToppCell	(10)_Ciliated-(2)_GFP_FOXI1\|(10)_Ciliated / shred by cell type by condition	GNAS CEP162 USP16 VPS13D AKAP9 CPEB4 CSPP1	6.59e-05	199	223	7	61b1ed2db71b96157b92b7535d1955a4033098da
ToppCell	LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	MATN2 PTCH1 ITGA9 NALCN KCNH2 PZP CACNA2D1	6.59e-05	199	223	7	6b3a0e5d52a30d0eed30e6a670f5b53bc233f70c
ToppCell	Parenchymal-NucSeq-Immune_Myeloid-Mast_cell\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ITGA9 ITGAM PTGS1 XYLT1 KCNH2 FER PZP	6.80e-05	200	223	7	9156f8fd61a833891d2f7b7fadd693b81b1e2d5a
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_anti-infl-F\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	TRPM2 PTGS1 SLC37A2 SLC2A5 TRABD TMEM102 ADAP2	6.80e-05	200	223	7	74ceebee9af63f8b3ec5857eff1b662752bc3862
ToppCell	Parenchymal-NucSeq-Immune_Myeloid-Mast_cell-Mast_cell\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ITGA9 ITGAM PTGS1 XYLT1 KCNH2 FER PZP	6.80e-05	200	223	7	566fe2e78e6f35399ec6aad5964f6d4d8ade82c6
ToppCell	LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	MATN2 PTCH1 ITGA9 NALCN KCNH2 PZP RAB34	6.80e-05	200	223	7	87827041663013f5e7273168dc8709d69840e7ce
ToppCell	(5)_Fibroblasts-(5)_Fibroblast-H\|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4)	HSPA9 VCP IPO4 SLC1A5 SLC6A9 ASNS ATIC	6.80e-05	200	223	7	0ebc54d19873a2b7b6d12b81559cb12abd73b90c
ToppCell	Control_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast\|Control_saline / Treatment groups by lineage, cell group, cell type	MATN2 PTCH1 ITGA9 KCNH2 PZP CACNA2D1 RAB34	6.80e-05	200	223	7	a799fc7bb83ad0524362cb5010df949741fb7bf3
ToppCell	droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Mesenchymal-fibroblast_of_cardiac_tissue\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MATN2 PMEPA1 NALCN C4A GRIK2 RAB34	6.91e-05	138	223	6	d5342383c5e52b92c39d7afe76560501be3ea5cd
ToppCell	droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Mesenchymal-fibroblast\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MATN2 PMEPA1 NALCN C4A GRIK2 RAB34	6.91e-05	138	223	6	e2659949944bdf39b23c7275e380a7a937e2726c
ToppCell	facs-Liver-Hepatocytes-3m-Epithelial-hepatocyte\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	C4A HSPB8 EPB41L4B ACOT12 EHHADH CES3	7.19e-05	139	223	6	4ddfbc36a0560fb70594627178bff652ab1ea3e9
ToppCell	facs-Liver-Hepatocytes-3m-Epithelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	C4A HSPB8 EPB41L4B ACOT12 EHHADH CES3	7.19e-05	139	223	6	82bf5ba69a907fbd9b4e2b2dd1dd27b8c4c75f25
ToppCell	facs-Liver-Hepatocytes-3m-Epithelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	C4A HSPB8 EPB41L4B ACOT12 EHHADH CES3	7.19e-05	139	223	6	fc9ac09c2106e88104a52575832d71d17765eec8
ToppCell	facs-Liver-Hepatocytes-3m\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	C4A HSPB8 EPB41L4B ACOT12 EHHADH CES3	7.19e-05	139	223	6	fc4b39ac9a10cf0acacfebbc4295edf324d930d5
ToppCell	E16.5-samps-Myeloid-Macrophage\|E16.5-samps / Age Group, Lineage, Cell class and subclass	TRPM2 SLC37A2 SLC2A5 RAB34 ADAP2 SP140	1.02e-04	148	223	6	cd5f697d8c2f272be1f3f52a05446749278431c5
ToppCell	E16.5-samps-Myeloid-Macrophage-CD163+_Macrophage\|E16.5-samps / Age Group, Lineage, Cell class and subclass	TRPM2 SLC37A2 SLC2A5 RAB34 ADAP2 SP140	1.02e-04	148	223	6	56e146980a71b5ca655118ae13310c5949220d4a
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Akr1c18_Ntf3\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	MATN2 PTGS1 KCNH2 HSPB8 GALNTL6 FLT3	1.06e-04	149	223	6	1e77f03d2b32f366018fec3462d1b75f6e7febb9
Drug	sodium	SLC36A1 KCNH7 TRPM2 PTGS1 RYR1 BLM KCNH2 HSPA9 AMBP CACNA2D1 REN GRIK4 SLC1A5 SLC1A7 SLC2A5 ACTR1B SLC6A9 ACTR1A CRYZ SLC9A3 AKAP9 SLC18A1 PDP1 SLC22A3 MTR PRKCH	1.77e-06	944	221	26	CID000000923
Drug	Prazosin hydrochloride [19237-84-4]; Down 200; 9.6uM; HL60; HT_HG-U133A	ZNF93 SREBF1 CDK14 GGCX FER DDX17 ARFGEF1 SLC1A7 VPS13D DNM3 SP140	3.11e-06	193	221	11	3098_DN
Drug	natrin	RYR1 KCNH2 CACNA2D1	3.58e-06	4	221	3	CID000019130
Drug	L-Glutamic Acid	GGCX OPLAH FOLH1 GRIK2 GRIK4 SLC1A7 ASNS	4.33e-06	68	221	7	DB00142
Drug	Ethaverine hydrochloride [985-13-7]; Up 200; 9.2uM; HL60; HT_HG-U133A	PMEPA1 PTGS1 RYR1 ADRB1 ELAPOR1 PCDHGB6 TP53I11 SLC1A7 DNAH17 CES3	1.53e-05	187	221	10	3037_UP
Drug	N-methyl mesoporphyrin IX	BLM RECQL4 RECQL	1.77e-05	6	221	3	CID000656404
Drug	enoximone	RYR1 CACNA2D1 REN PDP1	1.86e-05	17	221	4	CID000053708
Drug	losartan	ITGA9 ITGAM ITGAV PTGS1 ADRB1 KCNH2 CACNA2D1 ITGA8 REN ACTR1B ACTR1A SLC9A3 TXNRD3 PRKCH	2.14e-05	378	221	14	CID000003961
Drug	Chlorprothixene hydrochloride [6469-93-8]; Down 200; 11.4uM; PC3; HT_HG-U133A	BMS1 CUL9 GPR3 SIN3B CEP162 FASTKD2 OPA1 ZNF253 MTR ZNF85	2.30e-05	196	221	10	6692_DN
Drug	N-methyl-DL-aspartic acid	RELN ADGRV1 PTCH1 PTGS1 RYR1 C4A GNAS FLII CACNA2D1 FOLH1 NTRK1 GRIK2 GRIK4 SLC1A7 SLC6A9 AKAP9 CPEB4 PRKCH ENO2	2.34e-05	655	221	19	CID000004376
Drug	Pseudopelletierine hydrochloride [6164-62-1]; Up 200; 21uM; MCF7; HT_HG-U133A	INTS1 SREBF1 CAMTA2 ZNF442 VDR TP53I11 PTPRU AKAP9 CES3 MAP2K5	2.40e-05	197	221	10	2766_UP
Drug	Spaglumic acid [4910-46-7]; Up 200; 13.2uM; MCF7; HT_HG-U133A	BTG2 DNM1 TP53I11 SIPA1 CPT1A SLC1A7 DNAH17 NEURL1 CES3 MAP2K5	2.62e-05	199	221	10	7465_UP
Drug	ATP betaS	CLPX BLM RECQL4 NTRK1 RECQL RFC1 ACTR1B ACTR1A PRKCH	3.04e-05	162	221	9	CID005311341
Drug	Azumoleno	RYR1 CACNA2D1 SLC18A1	3.07e-05	7	221	3	CID000056259
Drug	dibutyryl cyclic 3',5'-AMP	ITGAM PTGS1 ITFG1 ADRB1 C4A GNAS CACNA2D1 LAMB2 REN CPT1A ACTR1B ACTR1A LIPE PDP1 PRKCH ATIC ENO2	3.71e-05	561	221	17	CID000002460
Drug	8-OHdG	TSC2 PTGS1 RECQL4 DNTT AMBP NEIL1 CRYZ ELAVL3	4.09e-05	130	221	8	CID000073318
Drug	desethylchloroquine	PDCD2 CYP2C8 OPA1	4.87e-05	8	221	3	CID000095478
Drug	gamma-carboxyglutamic acid	EPHX1 GGCX TYRO3 C4A VDR RCE1 ARSL	5.86e-05	101	221	7	CID000040772
Drug	phenytoin	EPHX1 PCYT1A CYP2C8 PTCH1 RYR1 KCNH2 CACNA2D1 REN LIPE ARSL	5.90e-05	219	221	10	CID000001775
Drug	Ringer's lactate	RELN ITGAM AMBP LIPE ABCE1	6.57e-05	44	221	5	CID006335487
Drug	AC1MNBOT	ITGAM FBXO3 DNTT ENO2	6.62e-05	23	221	4	CID003350247
Drug	glutamate	RELN TRPM2 CLPX GGCX RYR1 CTPS2 GNAS OPLAH CACNA2D1 FOLH1 GRIK2 GRIK4 CPT1A SLC1A5 SLC1A7 ACTR1B SLC6A9 ACTR1A PDP1 ASNS MTR PRKCH ENO2	6.66e-05	962	221	23	CID000000611
Drug	carbamazepine-10,11-epoxide	EPHX1 PDCD2 CYP2C8	7.26e-05	9	221	3	CID000002555
Drug	chiglitazar	CPT1A LIPE EHHADH	7.26e-05	9	221	3	ctd:C515629
Drug	Monensin	ATP7A TRPM2 SLC6A9	7.26e-05	9	221	3	ctd:D008985
Drug	Corticosterone	SREBF1 PTGS1 JAK2 BTG2 KCNH2 OPLAH ITGA8 TRIM54 CPT1A SLC22A3 ASNS	7.58e-05	272	221	11	ctd:D003345
Drug	AC1L1J5B	PDCD2 RYR1 KCNH2 REN	7.88e-05	24	221	4	CID000004872
Drug	AC1L1G5B	PDCD2 KAT2A PTGS1 KAT2B CRYZ	8.16e-05	46	221	5	CID000003531
Drug	AC1L1GI5	CES1 ADRB1 GNAS CACNA2D1 REN	9.06e-05	47	221	5	CID000003693
Drug	genistein	HNRNPM ITGA9 ITGAM ITGAV PMEPA1 PTGS1 RYR1 JAK2 ERCC8 KAT2B KCNH2 PZP VDR CACNA2D1 TP53I11 ITGA8 LAMB2 CPT1A ACTR1B ACTR1A CRYZ PRKCH ATIC MAP2K5 ENO2	9.11e-05	1117	221	25	CID005280961
Drug	N-(all-trans-retinoyl)-DL-leucine	RELN C4A	9.38e-05	2	221	2	CID006439237
Drug	retinoylglycine	RELN C4A	9.38e-05	2	221	2	CID005379396
Drug	ZENECA ZM224,832	CACNA2D1 REN	9.38e-05	2	221	2	CID000195507
Drug	11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene	JAK2 FLT3	9.38e-05	2	221	2	ctd:C561234
Drug	4-nitrophenyl butyrate	CES1 CES3	9.38e-05	2	221	2	ctd:C033592
Drug	Cyclandelate	CES1 CACNA2D1	9.38e-05	2	221	2	DB04838
Drug	norethisterone oenanthate	RELN PTCHD3 C4A FLII NTRK1 EHHADH ENO2	9.51e-05	109	221	7	CID000019688
Drug	Lansoprazole [103577-45-3]; Down 200; 10.8uM; HL60; HT_HG-U133A	PTCH1 PTGS1 ERCC8 BTG2 AHNAK MFSD9 SLC2A5 TRABD ENO2	1.00e-04	189	221	9	2967_DN
Drug	Ibutilide	KCNH7 KCNH2 CACNA2D1	1.03e-04	10	221	3	DB00308
Drug	AC1OAH54	FBP2 DNTT ATIC	1.03e-04	10	221	3	CID006857729
Drug	Penicillamine	ATP7A SREBF1 PTGS1 C4A C4B CPT1A MTR	1.07e-04	111	221	7	ctd:D010396
Drug	Fluvastatin sodium salt [93957-55-2]; Up 200; 9.2uM; MCF7; HT_HG-U133A	CUL9 FLII RECQL BTBD2 RFC1 BTBD7 PDP1 PRKCH ZNF85	1.09e-04	191	221	9	5290_UP
Drug	hydroxycitrate	PCYT1A CPT1A ACOT12 PDP1	1.09e-04	26	221	4	CID000123908
Drug	hydroxyl radicals	EPHX1 CYP2C8 ATP7A PTCHD3 CES1 FBP2 ALDH1L1 PTGS1 GGCX GANAB CTPS2 DNM1 OPLAH NTRK1 PON3 PTPRU USP16 ACOT12 LIPE ARSL EHHADH PDP1 ASNS DNM3 MTR PRKCH ATIC ENO2	1.11e-04	1341	221	28	CID000000961
Drug	Tetrahydroalstonine [6474-90-4]; Up 200; 11.4uM; MCF7; HT_HG-U133A	PCYT1A ZNF442 FER DNM1 CEP162 BTBD2 BTBD7 NEURL1 SLC16A7	1.18e-04	193	221	9	6209_UP
Drug	creatine	MEA1 RYR1 AMBP CACNA2D1 SLC1A5 SLC1A7 LIPE SLC18A1 MTR	1.18e-04	193	221	9	CID000000586
Drug	Epinephrine	ITGAV PTGS1 ADRB1 HSPA9 REN LIPE SLC22A3	1.19e-04	113	221	7	ctd:D004837
Drug	Meclozine dihydrochloride [1104-22-9]; Up 200; 8.6uM; MCF7; HT_HG-U133A	INTS1 CUL9 VDR TP53I11 SIPA1 SLC1A5 ASNS DNAH17 MAP2K5	1.23e-04	194	221	9	3285_UP
Drug	Chlormezanone [80-77-3]; Down 200; 14.6uM; HL60; HG-U133A	PCYT1A MYO9A CDK14 UBR5 VCP VDR DDX17 WDR47 MAP2K5	1.32e-04	196	221	9	1620_DN
Drug	Benzthiazide [91-33-8]; Down 200; 9.2uM; MCF7; HT_HG-U133A	PCYT1A NPM3 BTG2 KCNH2 FER VDR PRKCH CSPP1 ADAP2	1.32e-04	196	221	9	3329_DN
Drug	Pipemidic acid [51940-44-4]; Down 200; 13.2uM; HL60; HT_HG-U133A	PTGS1 GNAS GPR3 MFSD9 FASTKD2 SLC2A5 VPS13D AKAP9 MAP2K5	1.32e-04	196	221	9	3093_DN
Drug	Gabazine [105538-73-6]; Up 200; 10.8uM; MCF7; HT_HG-U133A	CABP5 ZNF442 NPM3 BTG2 KCNH2 FLT3 TP53I11 LIPE SP140	1.32e-04	196	221	9	3253_UP
Drug	Triamterene [396-01-0]; Down 200; 15.8uM; HL60; HT_HG-U133A	EPHX1 GGCX B3GAT3 JAK2 FBXO3 VPS54 OPA1 VPS13D CSPP1	1.32e-04	196	221	9	1861_DN
Drug	Bupropion hydrochloride [31677-93-7]; Up 200; 14.4uM; HL60; HG-U133A	SECISBP2L TRPM2 ITGAM DNM1 ESYT1 ADGRA2 SLC1A7 MAP2K5 ENO2	1.38e-04	197	221	9	1564_UP
Drug	Phenindione [83-12-5]; Down 200; 18uM; MCF7; HT_HG-U133A	SREBF1 ZNF442 B3GAT3 UBR5 FER CEP162 PRKCH MAP2K5 SLC16A7	1.38e-04	197	221	9	2868_DN
Drug	Nadide [53-84-9]; Down 200; 6uM; MCF7; HT_HG-U133A	ZNF93 ALDH1L1 PTGS1 VDR TP53I11 FASTKD2 BTBD7 DNAH17 NEURL1	1.38e-04	197	221	9	6091_DN
Drug	2-propylpentanoic acid; Up 200; 1000uM; PC3; HG-U133A	SLC36A1 GANAB VDR GPR3 GALNT10 EMC9 LAMB2 ZNF253 MAP2K5	1.38e-04	197	221	9	458_UP
Drug	NSC406942	CABP5 CES1 FBP2 CLPX RYR1 DNM1 HSPA9 VDR FLII REN SLC2A5 ACTR1B ACTR1A ASNS DNM3 NGLY1	1.38e-04	565	221	16	CID000001115
Drug	Tetrahydrofolic acid	ALDH1L1 MTR ATIC	1.41e-04	11	221	3	DB00116
Drug	nASCs	ITGAM AMBP ENO2	1.41e-04	11	221	3	CID000114812
Drug	Propafenone	ADRB1 KCNH2 SLC22A3	1.41e-04	11	221	3	ctd:D011405
Drug	carbanilide	RYR1 KCNH2 PDP1	1.41e-04	11	221	3	CID000007595
Drug	3-butene-1,2-diol	EPHX1 GNAS AMBP	1.41e-04	11	221	3	CID000010338
Drug	Quinethazone [73-49-4]; Up 200; 13.8uM; PC3; HT_HG-U133A	PCYT1A THNSL1 ALDH1L1 BTG2 CACNA2D1 PCDHGB6 AFF3 DNAH17 CES3	1.43e-04	198	221	9	4529_UP
Drug	cis-4,7,10,13,16,19-Docosahexaenoic acid ethyl ester; Down 200; 100uM; PC3; HG-U133A	KCNH2 HSPA9 GPR3 TP53I11 PON3 SIPA1 NEURL1 CSPP1 ADAP2	1.43e-04	198	221	9	664_DN
Drug	Amitryptiline hydrochloride [549-18-8]; Down 200; 12.8uM; MCF7; HT_HG-U133A	THNSL1 CAMTA2 KCNH2 FER DPYSL4 CPT1A ECHDC3 BTBD7 SLC16A7	1.43e-04	198	221	9	1701_DN
Drug	Trimethoprim [738-70-5]; Up 200; 13.8uM; MCF7; HT_HG-U133A	ZNF442 KCNH2 AHNAK FLII SIPA1 CES3 ELAVL3 CSPP1 SLC16A7	1.43e-04	198	221	9	4701_UP
Drug	Oleandomycin phosphate [7060-74-4]; Up 200; 5uM; HL60; HG-U133A	SECISBP2L ZNF93 INTS1 TSC2 ERCC8 FBXO3 GINS3 VPS13D MAP2K5	1.43e-04	198	221	9	2018_UP
Drug	Salmeterol Xinafoate	CYP2C8 ADRB1 KCNH2 SLC22A3	1.47e-04	28	221	4	ctd:D000068299
Drug	Propranolol hydrochloride [318-98-9]; Up 200; 13.6uM; MCF7; HT_HG-U133A	DNM1 VDR CEP162 TP53I11 ARFGEF1 SLC1A7 AKAP9 TRABD DNAH17	1.48e-04	199	221	9	5358_UP
Drug	Metoprolol-(+,-) (+)-tartrate salt [56392-17-7]; Up 200; 5.8uM; HL60; HT_HG-U133A	MATN2 ITGAM AHNAK HS3ST2 CACNA2D1 LAMB2 CPT1A SLC18A1 DNM3	1.48e-04	199	221	9	2543_UP
Drug	Diphenylpyraline hydrochloride [132-18-3]; Down 200; 12.6uM; MCF7; HT_HG-U133A	CYP2C8 ALDH1L1 GNAS CEP162 SLC2A5 CD1E VPS13D NEURL1 ADAP2	1.48e-04	199	221	9	3640_DN
Disease	Schizophrenia	RELN SREBF1 ITGAM PTGS1 KCNH2 MICB GNAS DNM1 HSPA9 FOLH1 NTRK1 ITGA8 GRIK2 GRIK4 OPA1 SLC6A9 SLC18A1 PLA2G4B MTR ENO2 GABBR1	3.26e-06	883	220	21	C0036341
Disease	Obesity	CES1 SREBF1 ALDH1L1 ITGAM ADRB1 GNAS NEIL1 SLC22A3 PRKCH SLC16A7	3.53e-06	205	220	10	C0028754
Disease	total cholesterol measurement, triglyceride measurement, low density lipoprotein cholesterol measurement, high density lipoprotein cholesterol measurement	NHLRC2 ADRB1 CPT1A CPEB4 DNM3	3.21e-05	49	220	5	EFO_0004530, EFO_0004574, EFO_0004611, EFO_0004612
Disease	triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement	CES1 NHLRC2 ITGAM PMEPA1 ADRB1 CPT1A SLC18A1 SLC22A3 HELZ2	5.22e-05	225	220	9	EFO_0008317, EFO_0020947
Disease	Bipolar Disorder	RELN TRPM2 HLA-G ITGA9 ITGAM VDR NTRK1 GRIK2 REN GRIK4 EHHADH SLC18A1 MTR	6.70e-05	477	220	13	C0005586
Disease	Precursor Cell Lymphoblastic Leukemia Lymphoma	EPHX1 CYP2C8 BLM JAK2 FLT3	9.33e-05	61	220	5	C1961102
Disease	hyperglycemia (is_marker_for)	PTCH1 ITGAM ITGAV	1.11e-04	13	220	3	DOID:4195 (is_marker_for)
Disease	neurodegenerative disease (implicated_via_orthology)	PTCH1 AFG3L2 VCP PON3 GRIK2 SLC1A5 SLC1A7	1.13e-04	145	220	7	DOID:1289 (implicated_via_orthology)
Disease	Alzheimer's disease (is_marker_for)	EPHX1 RELN TSC2 PTGS1 GNAS DNM1 HSPA9 NTRK1 OPA1	1.44e-04	257	220	9	DOID:10652 (is_marker_for)
Disease	apolipoprotein A 1 measurement	CES1 HNRNPM HLA-G NHLRC2 ITGAM PMEPA1 GPR180 TYRO3 ADRB1 FER FLT3 AFF3 PTPRU CPT1A SLC18A1 CES3 CDH16	2.29e-04	848	220	17	EFO_0004614
Disease	Prescription Drug Abuse	XYLT1 AFF3 GRIK2 EHHADH SLC22A3 PRKCH	2.30e-04	115	220	6	C4316881
Disease	Substance-Related Disorders	XYLT1 AFF3 GRIK2 EHHADH SLC22A3 PRKCH	2.30e-04	115	220	6	C0236969
Disease	Organic Mental Disorders, Substance-Induced	XYLT1 AFF3 GRIK2 EHHADH SLC22A3 PRKCH	2.30e-04	115	220	6	C0029231
Disease	Drug habituation	XYLT1 AFF3 GRIK2 EHHADH SLC22A3 PRKCH	2.30e-04	115	220	6	C0013170
Disease	Drug abuse	XYLT1 AFF3 GRIK2 EHHADH SLC22A3 PRKCH	2.30e-04	115	220	6	C0013146
Disease	Drug Use Disorders	XYLT1 AFF3 GRIK2 EHHADH SLC22A3 PRKCH	2.30e-04	115	220	6	C0013222
Disease	Drug Dependence	XYLT1 AFF3 GRIK2 EHHADH SLC22A3 PRKCH	2.30e-04	115	220	6	C1510472
Disease	Substance Dependence	XYLT1 AFF3 GRIK2 EHHADH SLC22A3 PRKCH	2.30e-04	115	220	6	C0038580
Disease	Substance Use Disorders	XYLT1 AFF3 GRIK2 EHHADH SLC22A3 PRKCH	2.30e-04	115	220	6	C0038586
Disease	Substance abuse problem	XYLT1 AFF3 GRIK2 EHHADH SLC22A3 PRKCH	2.41e-04	116	220	6	C0740858
Disease	hypertension (is_implicated_in)	ITGA9 ADRB1 GNAS REN LIPE MTR	3.02e-04	121	220	6	DOID:10763 (is_implicated_in)
Disease	alcoholic hepatitis (biomarker_via_orthology)	SREBF1 FGF19 CPT1A	3.07e-04	18	220	3	DOID:12351 (biomarker_via_orthology)
Disease	Depression, Bipolar	RELN TRPM2 NTRK1 GRIK2 GRIK4	3.17e-04	79	220	5	C0005587
Disease	survival time, pneumonia, septic shock, Sepsis	FER GRIK2	3.29e-04	4	220	2	EFO_0000714, EFO_0003106, EFO_0006834, HP_0100806
Disease	Short QT Syndrome 1	KCNH2 CACNA2D1	3.29e-04	4	220	2	C1865020
Disease	liver cancer (implicated_via_orthology)	JAK2 ACOT12	3.29e-04	4	220	2	DOID:3571 (implicated_via_orthology)
Disease	colorectal cancer, inflammatory bowel disease	PTCHD3 GRIK2 SP140	3.63e-04	19	220	3	EFO_0003767, MONDO_0005575
Disease	Adverse reaction to drug	CYP2C8 AMBP REN MTR ATIC	4.21e-04	84	220	5	C0041755
Disease	Drug toxicity	CYP2C8 AMBP REN MTR ATIC	4.21e-04	84	220	5	C0013221
Disease	very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio	HLA-G NHLRC2 ITGAM ADRB1 SIPA1 CPT1A SLC18A1 SLC22A3	4.53e-04	239	220	8	EFO_0008317, EFO_0020945
Disease	portal hypertension (is_implicated_in)	JAK2 REN	5.45e-04	5	220	2	DOID:10762 (is_implicated_in)
Disease	centronuclear myopathy 1 (implicated_via_orthology)	DNM1 DNM3	5.45e-04	5	220	2	DOID:0111223 (implicated_via_orthology)
Disease	microcytic anemia (implicated_via_orthology)	DNM1 DNM3	5.45e-04	5	220	2	DOID:11252 (implicated_via_orthology)
Disease	Gaucher disease	NHLRC2 ADRB1	5.45e-04	5	220	2	MONDO_0018150
Disease	liver cancer (biomarker_via_orthology)	CES1 JAK2	5.45e-04	5	220	2	DOID:3571 (biomarker_via_orthology)
Disease	Charcot-Marie-Tooth disease dominant intermediate B (implicated_via_orthology)	DNM1 DNM3	5.45e-04	5	220	2	DOID:0110197 (implicated_via_orthology)
Disease	Brugada Syndrome (disorder)	KCNH2 CACNA2D1 AKAP9	7.37e-04	24	220	3	C1142166
Disease	disease of metabolism (is_implicated_in)	EPHX1 SREBF1	8.14e-04	6	220	2	DOID:0014667 (is_implicated_in)
Disease	episodic ataxia type 6 (implicated_via_orthology)	SLC1A5 SLC1A7	8.14e-04	6	220	2	DOID:0050994 (implicated_via_orthology)
Disease	Psychotic Disorders	TRPM2 KCNH2 NTRK1 GRIK4 SLC6A9	9.76e-04	101	220	5	C0033975
Disease	congestive heart failure (is_implicated_in)	RYR1 ADRB1 NISCH	1.05e-03	27	220	3	DOID:6000 (is_implicated_in)
Disease	Insulin Sensitivity	SREBF1 ITGAM GNAS NEIL1	1.06e-03	60	220	4	C0920563
Disease	Insulin Resistance	SREBF1 ITGAM GNAS NEIL1	1.06e-03	60	220	4	C0021655
Disease	level of oxylipin in blood plasma	ITGA9 GRIK2	1.13e-03	7	220	2	OBA_2050338
Disease	serine:glycine ratio	ALDH1L1 PTPRU	1.13e-03	7	220	2	EFO_0021777
Disease	Malignant neoplasm of breast	ITGA9 PTGS1 GPR180 ELAPOR1 VDR RCE1 PCDHGB6 MFSD9 RECQL GRIK2 CPT1A SLC2A5 NLRP9 LIPE AKAP9 NISCH MTR CYB5R4	1.22e-03	1074	220	18	C0006142
Disease	basal cell carcinoma (is_marker_for)	PTCH1 VDR	1.50e-03	8	220	2	DOID:2513 (is_marker_for)
Disease	heart conduction disease (implicated_via_orthology)	KCNH7 SREBF1 KCNH2	1.73e-03	32	220	3	DOID:10273 (implicated_via_orthology)
Disease	Nonorganic psychosis	TRPM2 KCNH2 GRIK4 SLC6A9	1.78e-03	69	220	4	C0349204
Disease	renovascular hypertension (implicated_via_orthology)	PTGS1 ADRB1	1.92e-03	9	220	2	DOID:1591 (implicated_via_orthology)
Disease	Leukemia, Myelocytic, Acute	EPHX1 TSC2 BLM JAK2 FLT3 ENO2	1.95e-03	173	220	6	C0023467
Disease	Manic Disorder	RELN TRPM2 NTRK1 GRIK2	1.98e-03	71	220	4	C0024713
Disease	esophagus squamous cell carcinoma (is_marker_for)	PTCH1 JAK2 KAT2B SLC1A5	2.30e-03	74	220	4	DOID:3748 (is_marker_for)
Disease	waist-hip ratio, high density lipoprotein cholesterol measurement	NHLRC2 ADRB1	2.39e-03	10	220	2	EFO_0004343, EFO_0004612
Disease	abdominal obesity-metabolic syndrome (implicated_via_orthology)	DDX17 NEIL1	2.39e-03	10	220	2	DOID:0060611 (implicated_via_orthology)
Disease	long QT syndrome (implicated_via_orthology)	KCNH7 KCNH2	2.39e-03	10	220	2	DOID:2843 (implicated_via_orthology)
Disease	duodenal ulcer	GNAS FLT3 SLC22A3	2.43e-03	36	220	3	EFO_0004607
Disease	Colorectal Carcinoma	ALDH1L1 ZNF442 GNAS PZP PDZRN4 FLNC FOLH1 ARFGEF1 PTPRU SLC1A7 AKAP9 ABCE1 NEURL1	2.49e-03	702	220	13	C0009402
Disease	Acute Myeloid Leukemia, M1	EPHX1 TSC2 JAK2 FLT3 ENO2	2.50e-03	125	220	5	C0026998
Disease	Acute Myeloid Leukemia (AML-M2)	EPHX1 TSC2 JAK2 FLT3 ENO2	2.50e-03	125	220	5	C1879321
Disease	breast cancer (is_marker_for)	TSC2 PMEPA1 PTGS1 KAT2B BTG2 VDR	2.73e-03	185	220	6	DOID:1612 (is_marker_for)
Disease	Manic	RELN TRPM2 NTRK1 GRIK2	2.79e-03	78	220	4	C0338831
Disease	heart disease (implicated_via_orthology)	KAT2A KAT2B LIPE	2.85e-03	38	220	3	DOID:114 (implicated_via_orthology)
Disease	Cerebral Infarction, Left Hemisphere	VDR PRKCH	2.91e-03	11	220	2	C0751010
Disease	Anterior Choroidal Artery Infarction	VDR PRKCH	2.91e-03	11	220	2	C0751012
Disease	Cerebral Infarction, Right Hemisphere	VDR PRKCH	2.91e-03	11	220	2	C0751011
Disease	Subcortical Infarction	VDR PRKCH	2.91e-03	11	220	2	C0751014
Disease	Cerebral Infarction	VDR PRKCH	2.91e-03	11	220	2	C0007785
Disease	Shortened QT interval	KCNH2 CACNA2D1	2.91e-03	11	220	2	C0151879
Disease	Posterior Choroidal Artery Infarction	VDR PRKCH	2.91e-03	11	220	2	C0887799
Disease	lignoceroylcarnitine (C24) measurement	CPT1A SLC1A7	2.91e-03	11	220	2	EFO_0800541
Disease	Congenital long QT syndrome	KCNH2 AKAP9	2.91e-03	11	220	2	cv:C1141890
Disease	Graves' disease (is_implicated_in)	C4A C4B VDR	3.07e-03	39	220	3	DOID:12361 (is_implicated_in)
Disease	Lymphoma	EPHX1 BLM MTR	3.30e-03	40	220	3	C0024299
Disease	body height at birth	NHLRC2 PTCH1 ADRB1	3.30e-03	40	220	3	EFO_0006784
Disease	testosterone measurement	PCYT1A CYP2C8 TRPM2 PMEPA1 GPR180 KAT2B SERPINB8 USH2A VDR CACNA2D1 TP53I11 MFSD9 REN LIPE NISCH SLC22A3 CPEB4 DNM3 TMEM102	3.37e-03	1275	220	19	EFO_0004908
Disease	rotator cuff tear, shoulder impingement syndrome	FRMPD4 ACOT9	3.48e-03	12	220	2	EFO_1001178, EFO_1001250
Disease	collagen disease (implicated_via_orthology)	DNM1 DNM3	3.48e-03	12	220	2	DOID:854 (implicated_via_orthology)
Disease	basal cell carcinoma (is_implicated_in)	PTCH1 VDR	3.48e-03	12	220	2	DOID:2513 (is_implicated_in)
Disease	Long QT syndrome	KCNH2 AKAP9	3.48e-03	12	220	2	cv:C0023976
Disease	acute myeloid leukemia (is_implicated_in)	EPHX1 ITGAV JAK2 FLT3	3.64e-03	84	220	4	DOID:9119 (is_implicated_in)
Disease	erectile dysfunction	MATN2 XYLT1 PDZRN4	3.79e-03	42	220	3	EFO_0004234
Disease	autistic disorder (is_implicated_in)	RELN C4B MTR	3.79e-03	42	220	3	DOID:12849 (is_implicated_in)
Disease	very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio	HLA-G NHLRC2 ADRB1 SIPA1 CPT1A SLC18A1 HELZ2	3.80e-03	264	220	7	EFO_0008317, EFO_0020944
Disease	hereditary spastic paraplegia (implicated_via_orthology)	AFG3L2 DNM1 DNM3	4.05e-03	43	220	3	DOID:2476 (implicated_via_orthology)
Disease	developmental and epileptic encephalopathy (implicated_via_orthology)	DNM1 DNM3	4.09e-03	13	220	2	DOID:0112202 (implicated_via_orthology)
Disease	survival time, breast carcinoma	KCNH7 ECHDC3	4.09e-03	13	220	2	EFO_0000305, EFO_0000714
Disease	feeling nervous measurement	PMEPA1 IRF2BPL CACNA2D1 ASNS	4.13e-03	87	220	4	EFO_0009597
Disease	PR interval	CUL9 SLC25A26 NHLRC2 ALDH1L1 ITGA9 ADRB1 FER HSPB8 LAMB2 OTUD7A	4.22e-03	495	220	10	EFO_0004462
Disease	Endogenous depression	PDCD2 RELN GNAS	4.90e-03	46	220	3	C0011573
Disease	type 2 diabetes mellitus (biomarker_via_orthology)	CYP2C8 SREBF1 ITGAM CPT1A MTR	5.00e-03	147	220	5	DOID:9352 (biomarker_via_orthology)
Disease	serum metabolite measurement	PCYT1A CYP2C8 ALDH1L1 ITGAM MFSD4B FER OPLAH PDZRN4 CACNA2D1 FOLH1 GRIK2 GRIK4 CPT1A SLC9A3 DNAH17	5.07e-03	945	220	15	EFO_0005653
Disease	systolic blood pressure, alcohol consumption measurement	NHLRC2 ADRB1 SIPA1	5.21e-03	47	220	3	EFO_0006335, EFO_0007878
Disease	Meckel-Gruber syndrome	WDPCP CSPP1	5.45e-03	15	220	2	C0265215
Disease	infant head circumference	NHLRC2 ADRB1	5.45e-03	15	220	2	EFO_0004577
Disease	16a-hydroxy DHEA 3-sulfate measurement	PCYT1A CYP2C8	5.45e-03	15	220	2	EFO_0800301
Disease	Kidney Failure, Chronic	SREBF1 PTGS1 CPT1A	5.52e-03	48	220	3	C0022661
Disease	Colonic Neoplasms	ATP7A KCNH2 CACNA2D1 GRIK2 RFC1	5.75e-03	152	220	5	C0009375
Disease	lung adenocarcinoma (is_implicated_in)	PTCH1 JAK2 UBR5	5.85e-03	49	220	3	DOID:3910 (is_implicated_in)
Disease	Depressive disorder	RELN ADRB1 FOLH1 REN SLC18A1 MTR MAP2K5	6.18e-03	289	220	7	C0011581

Protein segments in the cluster

Peptide	Gene	Start	Entry
VIGFAKMIPGFRDLT	VDR	241	P11473
GVGIPEDSIFTMADR	AMBP	171	P02760
REFFNDLDLLMGPVT	AFF3	1186	P51826
ASADLVMGLLVVPFG	ADRB1	101	P08588
GVRPLFKAMTEDGFL	ASNS	141	P08243
FAIGMEDSPDLLAAR	ASNS	286	P08243
LFLDLIADVMFGVPS	CES1	416	P23141
IGDLPFVGAVSMFFI	ESYT1	251	Q9BSJ8
SRPFPVDMAGFAVAL	B3GAT3	246	O94766
RFILPIGATVNMDGA	SLC1A5	376	Q15758
ARMGGQPAFTDLEVI	AKAP9	3741	Q99996
LMDVFPTVVRLAGGE	ARSL	411	P51690
DLIEFGMIPEFVGRL	CLPX	486	O76031
GAPFLLQALVREMSG	C4B	381	P0C0L5
EFLEMFVGVGPARVR	AFG3L2	376	Q9Y4W6
VLMELSAFPREVGGA	ADGRA2	751	Q96PE1
LRMFLEGFRLPGEAQ	ARFGEF1	781	Q9Y6D6
RVMAGALEGDLFIGP	ACTR1B	46	P42025
VPAAGELLFEAGEMR	ADGRV1	4316	Q8WXG9
RSGFIVAEIEPMGVF	ADGRV1	4991	Q8WXG9
REDFVGLPEAGASMR	CAMTA2	956	O94983
PMRAIFLADGNVFTT	CORO1C	221	Q9ULV4
AGEGLARMELFLFLT	CYP2C8	436	P10632
RMTALAQDFAVGLGP	CPT1A	201	P50416
GGSRPFVVAVDDIMF	ACOT9	331	Q9Y305
DMFKFRGPSTVGDRL	ACOT12	231	Q8WYK0
FTFSGRELVGREMGV	AHNAK	5666	Q09666
IARFSPIAIDGMSGL	ELAVL3	256	Q14576
GGLMFPDRAALYVVA	PRMT8	211	Q9NR22
VRLQPEAGESMRAFG	CDK14	441	O94921
GIMPDFRIAATGVVL	BMS1	1001	Q14692
QEFMILPVGAESFRD	ENO2	166	P09104
LPVGAESFRDAMRLG	ENO2	171	P09104
EFMADGETISLPGNR	ADAP2	121	Q9NPF8
MIAEFIRELGFGATV	ATP7A	541	Q04656
MFIFAILPDGEVVGD	PZP	536	P20742
ITEDMLRGIFEPFGR	RBM39	261	Q14498
MGFALERFAEAVDPA	PDZRN4	1	Q6ZMN7
VLFSGIAIMALAFPD	TP53I11	71	O14683
GVDFEMERFEVLGIP	RAB34	86	Q9BZG1
KLMRAVRVFEFGGPE	CRYZ	6	Q08257
ISRGAEAPLLDDFVM	JAK2	136	O60674
DGRVIGGICFRMFPT	KAT2A	556	Q92830
ALGPDGSAFFDMVPR	PCDHGB6	566	Q9Y5F9
RGEPRFIAMGYVDDT	HLA-G	41	P17693
FVSGERLITDPAGEM	HS3ST2	271	Q9Y278
FGVCTEGRPLLMVFE	NTRK1	576	P04629
DFMLFVGLACSDPRV	OR11A1	181	Q9GZK7
AVYRLVLTAMDGGDP	PCDHGA6	206	Q9Y5G7
MEATGVLPFVRGVDL	FLII	1	Q13045
MFERSFTQGEGARPL	MATN2	741	O00339
LPVRGAVECLFEMGF	NGLY1	66	Q96IV0
EPLALVFRFGMSGSF	NEIL1	71	Q96FI4
LGPEDDLAGMFLQIF	INTS1	1346	Q8N201
DGRVIGGICFRMFPS	KAT2B	551	Q92831
LVGFLDLFGVSMVVP	MFSD9	51	Q8NBP5
LRVPAPVTMDSFFFG	NPM3	26	O75607
MVAAIPFDLLIFGSG	KCNH7	501	Q9NS40
HGIRTGLFTPDMAFE	DNM1	396	Q05193
ERRAVYIGALFPMSG	GABBR1	166	Q9UBS5
PFESPVMAGGLFAVD	GALNT10	311	Q86SR1
LSSRLLDDGFGMDPF	HSPB8	26	Q9UJY1
DNDFMILTLVVPGFR	ELAPOR1	466	Q6UXG2
GGMVFELANSIVLPF	FOLH1	581	Q04609
GFGLERMAAPIDRVG	HNRNPM	491	P52272
DMVAAIPFDLLIFGS	KCNH2	501	Q12809
GGRVDFDDFVELMTP	CABP5	81	Q9NP86
RGIDSLFSAPMDFRG	DKKL1	66	Q9UK85
HGIRTGLFTPDMAFE	DNM3	396	Q9UQ16
MGPFRVSDLAGLDVG	EHHADH	516	Q08426
GVDLFMLDPALGEFV	FBP2	181	O00757
MAAVAVLRAFGASGP	ECHDC3	1	Q96DC8
RNPAAIDMFIIGATF	FBXO3	231	Q9UK99
LLTLMGFRLEGIFPA	RCE1	101	Q9Y256
AVRFFKEGVPGADML	IRF2BPL	481	Q9H1B7
KSREFIGSFLEMFGP	PCYT1A	281	P49585
MAAAGARPVELGFAE	PDCD2	1	Q16342
SLGISFMELALGRFP	MAP2K5	341	Q13163
SPFAGMLFGGEDREL	CSPP1	401	Q1MSJ5
GLGTAMLRDFCETFP	FAM169B	91	Q8N8A8
RSPFEVNVGMALGDA	FLNC	361	Q14315
SMDPFGLVTGLEAVR	FGF19	196	O95750
FVDMFARPSVGLIAN	SLC16A7	291	O60669
LPRVLVLEMFSGGDA	LAMB2	721	P55268
MGLGRVLLFLAVAFP	MICB	1	Q29980
MLRDSGGEAFAPIPF	OTUD7A	326	Q8TE49
IPSELFGSEFFMGQL	PLA2G4B	471	P0C869
GVPFMGSLAEFFDIA	GPR180	236	Q86V85
IFGESMIEIGAPFSL	PTGS1	516	P23219
PTELFGSELFMGRLL	PLA2G4F	531	Q68DD2
EMAAAQGLVDARFPF	OSR2	71	Q8N2R0
SLNPILFRGVGMVAD	DDOST	191	P39656
FPGFSMLVGDFITAA	RALGAPA2	1071	Q2PPJ7
VAFTADGERLVGMPA	HSPA9	91	P38646
DRLLGLLMPFRAFGD	PDP1	341	Q9P0J1
RVMDPGFLDVSGISL	GORASP1	301	Q9BQQ3
FRAPMFLLVGSLAVA	GPR3	71	P46089
DDVLVGAPLFMEREF	ITGA8	336	P53708
GGERDPMNLFAFGDV	NHLRC2	451	Q8NBF2
MLGFLSARQTGLEDP	ERCC8	1	Q13216
AFFVIGASLGEMAIP	MFSD4B	356	Q5TF39
RFFPSGLVVLSGGMD	PAAF1	141	Q9BRP4
IFDSDLMDSARLGGP	PMEPA1	191	Q969W9
PADAGPVGRIAFDMF	RELN	2686	P78509
LFEALISPDRRGYMG	PTPRU	161	Q92729
EMIAQARIFPRGSGE	OPA1	306	O60313
FFTEELVVMGAPGSF	ITGA9	201	Q13797
RDGGQLPLLVVFSAM	FLT3	6	P36888
LGPLDRGDMLNEAFI	WDPCP	641	O95876
GMFISGVFGERLPLR	SLC37A2	101	Q8TED4
RVALEDGKMFVTPGA	DPYSL4	451	O14531
MPFSVREGINIFLDG	ABCE1	301	P61221
PRFLAGLMEAGESEL	CD1E	191	P15812
DSPGFLRFVRVLCGM	HECTD1	2516	Q9ULT8
MVRGGHFAAFEEPEL	EPHX1	426	P07099
LGMADTGFDLTPDVR	LACTBL1	211	A8MY62
TIAFGMGIDKPDVRF	BLM	946	P54132
FDMATGQFAAPLRGI	C1QTNF6	176	Q9BXI9
ARFVLPVGATINMDG	SLC1A7	366	O00341
LFDFLMPGFLGTERQ	BTAF1	1446	O14981
TDDLPVFMGLIGDLF	DNAH17	2061	Q9UFH2
VFMGLIGDLFPALDV	DNAH17	2066	Q9UFH2
IGRFFGEIDPSLMRH	CACNA2D1	871	P54289
IMELVSGGDFLTFLR	FER	636	P16591
MRRDPVLGFGFVAGS	FRMPD4	81	Q14CM0
ADVFIGAPLFMDRGS	ITGAV	321	P06756
SAFIGNAMDLLRIPG	TMEM63B	576	Q5T3F8
RVMAGALEGDIFIGP	ACTR1A	46	P61163
MKPIRIDSFGISGFD	CEP162	351	Q5TB80
EFGTPNSLDVDMRGL	BTBD7	226	Q9P203
IMEVRDMGGQPFGLF	DSC1	321	Q08554
AGSELFGPRAAFMLA	CUL9	1511	Q8IWT3
RRGQSSLFPMEDGFL	CPEB4	426	Q17RY0
SLFPMEDGFLDDGRG	CPEB4	431	Q17RY0
AGRIAEFFPDAVLIM	EMC9	101	Q9Y3B6
GFPLALSGRDMVGIA	DDX17	201	Q92841
ESGPMGAEELAFRFA	GRIK2	46	Q13002
IGMPVGSVFRDEFDL	GRIK4	751	Q16099
LMPDTDQGFLLGRAV	HELZ2	401	Q9BYK8
FVFGGPFLMDESSRL	CES3	466	Q6UWW8
LIRFPLMTIEEFAAG	BTBD2	316	Q9BX70
MDRPGFVAALVAGGV	SLC25A26	1	Q70HW3
GLFAGVFPRMAAISL	SLC25A26	236	Q70HW3
VFPRMAAISLGGFIF	SLC25A26	241	Q70HW3
MPSFDEALQRVGEFG	SLC22A3	1	O75751
VLDVGFLPDMRAAAS	RYR1	2521	P21817
RGGAFTLEPGDLLMD	EPB41L4B	746	Q9H329
ADPEVRSNAIFGMGV	IPO4	911	Q8TEX9
PAFRLMDFAIERGDT	CDH16	481	O75309
GAPFLLQALVREMSG	C4A	381	P0C0L4
NSPFLILGVGVDDMF	PTCHD3	446	Q3KNS1
MDRGLGVRAAFPEGF	LIPE	931	Q05469
AGFLTFLRGVMLVIP	OR52N1	146	Q8NH53
TVVLGGDTMGPERIF	MEA1	16	Q16626
PFESPVMAGGLFAVD	GALNTL6	306	Q49A17
GALEFMDEGDTLRPF	USH2A	3921	O75445
FIDIGINLTDPMFRG	TATDN1	6	Q6P1N9
TETAMPRLGAFFLER	GINS3	36	Q9BRX5
PGDIMFLLVQRFGEL	USP39	266	Q53GS9
AFLPDAFVTMTGGFR	DNTT	321	P04053
MGPFDVARKVFAAGE	RFC1	846	P35251
LRAGPFDEFQIATML	STK26	111	Q9P289
TVAFGMGLDRPDVRA	RECQL4	771	O94761
FVVPSVEGSMAERGA	TAF2	161	Q6P1X5
GTQARGDLFDLAVPM	OPLAH	111	O14841
LFMRSDGGLAPMDTF	OPLAH	266	O14841
MGFIEQAIGRVTPIF	REN	196	P00797
FENLGFRPVGLMDLF	FASTKD2	426	Q9NYY8
SGGMERPFVLARAFF	GANAB	591	Q14697
LEAFGPALMEPGAFS	GNAS	131	Q5JWF2
GRTGEFMEDFPLTLL	SLC2A5	56	P22732
FLLFGSLMAAVDPVA	SLC9A3	181	P48764
ALGAAEMRPFIEIIG	MTR	261	Q99707
GVLMLAGSEFDFIVR	PTCH1	1136	Q13635
RGRPFRGMSEEEVFT	SIN3B	201	O75182
FFGMDESLGPVAVSL	SIPA1	231	Q96FS4
AMAREQEIPFVFALG	SECISBP2L	761	Q93073
SFPMRAEDLEQLGGL	PPP1R3G	166	B7ZBB8
RALAFNGVMFGDRPL	SREK1	121	Q8WXA9
FMSLDCLVVGGPREF	ITGAM	786	P11215
EDLFLLAAGTGFTPM	CYB5R4	391	Q7L1T6
FLGTVDPRSEMAGFR	AARS2	86	Q5JTZ9
PFLRRLGMIDAFDEA	SERPINB8	281	P50452
FLSAPGQRVGMLAEA	SREBF1	1101	P36956
GTDMLPEIAAAVGFL	BTG2	6	P78543
FGPVMIISRFADGDL	ALDH1L1	806	O75891
FMDAVRVLPFDPRGA	CILP2	531	Q8IUL8
IFSQPERILFIMDGF	NLRP9	216	Q7RTR0
TVAFGMGIDKPDVRF	RECQL	371	P46063
EMLRTIDFQPGASGE	TRIM54	321	Q9BYV2
IRDLAFMEGPESGGA	WDR47	711	O94967
IGDIEGMPFVEAFRQ	CTPS2	151	Q9NRF8
SELMQLFPRGLFEDA	STK19	151	P49842
MGPLQFRDVAIEFSL	ZNF93	1	P35789
RLFRNFGGLLGPMDE	XYLT1	751	Q86Y38
FGFLMVLDIPQERGL	GGCX	71	P38435
MGLLAFRDVALEFSP	ZNF695	1	Q8IW36
MPSFVDRIFGGELTS	USP16	351	Q9Y5T5
AVMLFFSGVRTADPL	NEURL1	186	O76050
IFSFEGIGMVLPLEN	SLC36A1	266	Q7Z2H8
ETGAFFFLINGPEIM	VCP	261	P55072
EQLGMAPGGEFREAF	TRABD	161	Q9H4I3
DARGFTPVAFAMLGV	RHBDD2	131	Q6NTF9
EMPTDAFGDIVFTGL	TRPM2	121	O94759
GDLTEFGFLMPELCL	NISCH	766	Q9Y2I1
DAGFTLLVPMFSLDG	TMEM102	116	Q8N9M5
FVRGVTLEGAFDGIM	SLC6A9	331	P48067
PAARLGEMIETAYGE	THNSL1	306	Q8IYQ7
GVGLSLVGEMFLAFR	PON3	11	Q15166
VSELTGFPEMLGGRV	ATIC	51	P31939
MGPLQFRDVAIEFSL	ZNF626	1	Q68DY1
MIVFGGEDRSDLFLP	ZNF442	1	Q9H7R0
MGPLQFRDVAIEFSL	ZNF253	1	O75346
RSGVRMFKDVDFLAP	XNDC1N	106	Q6ZNB5
MGPLEFRDVAIEFSL	ZNF90	1	Q03938
GFLAGFGLDVTVMVR	TXNRD3	351	Q86VQ6
MGPLQFRDVAIEFSL	ZNF66	1	Q6ZN08
MGPLTFRDVAIEFSL	ZNF85	1	Q03923
FPFLMGLRDRSFISE	SP140	61	Q13342
MDFNGDLIPDIFGIT	ITFG1	161	Q8TB96
LRGGSFEFKDMRVPS	VIRMA	1021	Q69YN4
GSLEMGPLTFRDVAI	ZNF680	6	Q8NEM1
GQAFDSVMARGEPAV	TYRO3	461	Q06418
MGPLQFRDVAIEFSL	ZNF506	1	Q5JVG8
MEDAPLLRGAVFFVG	TSC2	286	P49815
LSLELFGRVFMEDVG	UBR5	2191	O95071
MFISDAFGEGELTPI	VPS54	516	Q9P1Q0
AIADVAFCMGFAIGP	SLC18A1	431	P54219
AARILGSVDFLGNPM	VPS13D	4061	Q5THJ4
MGPLQFRDVAIEFSL	ZNF737	1	O75373
PDRLFFVMEFVNGGD	PRKCH	426	P24723
PTAVIRDFGGVMDIF	NALCN	946	Q8IZF0
AFISGMIGIDPVAVF	MYO9A	686	B2RTY4